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Programmed cell death (PCD) is a phenomenon commonly associated with multicellular 
organisms. Caspases are the main mediators of PCD, and this class of proteases are 
responsible for many of the morphological and physiological changes observed during PCD. 
However, in recent years, growing evidence has suggested that PCD is not unique to 
metazoans; unicellular eukaryotes such as Saccharomyces cerevisiae, Trypanosoma brucei 
and Plasmodium spp. have also demonstrated hallmarks of apoptosis such as DNA laddering 
and phosphatidylserine externalization. Metacaspases are distant homologues of caspases 
identified through iterative PSI-BLAST searches, and they possess the same critical catalytic 
dyad of cysteine and histidine residues as caspases. In S. cerevisiae, a metacaspase YCA1 has 
been shown to be involved in the cell death pathway. Similarly, three metacaspases have been 
identified in P. falciparum, the most debilitating malaria parasite in humans. Of these three 
metacaspases, PfMCA1 bears the most similarity to YCA1, in terms of size and identity. To 
elucidate the role that PfMCA1 plays in plasmodial cell death, PfMCA1 will be expressed in 
yeast cells, and its effect on yeast cell death will be studied. However, it was found that 
PfMCA1 is toxic to a variety of host cells, and this toxicity is most likely due to its catalytic 
activity, as the non-catalytic domain could be successfully expressed while the catalytic 
domain could not. 







Malaria is one of the most prevalent human infections worldwide, with an estimated 
300 million clinical cases and approximately 1 million deaths occurring annually (World 
Health Organization, Roll Back Malaria). Malaria is caused by obligate intracellular parasitic 
protozoan species of the genus Plasmodium, family Plasmodiidae, suborder 
Haemosporidiidae, order Coccidia. Four species are known to infect humans, namely P. 
falciparum, P. vivax, P. malariae and P. ovale. Of these four species, P. falciparum is the 
most pathogenic, responsible for the majority of clinical cases and death (Suh et al., 2004). 
 
1.1.1 The malaria life cycle 
The malaria parasite spends its time between two hosts, an insect vector and a 
vertebrate host. In the case of humans, the parasites are exclusively transmitted by the 
anopheline mosquitoes; other mosquito species are responsible for transmitting the parasites 
in other animals, e.g. mosquitoes of the genus Culex can transmit avian malaria (Ejiri et al., 
2008). 
There are two phases of infection in the human host. The exoerythocytic stage begins 
with the bite of an infected anopheles mosquito. Infective sporozoites released into the 
bloodstream via the saliva of the mosquito travel to the liver, where they invade the 
hepatocytes and begin several rounds of replication. This process takes approximately a 
month; at the end, the sporozoites have matured into schizonts. In certain malaria species, 
such as P. vivax and P. ovale, infected hepatocytes may enter a phase of arrested development 
(Krotoski et al., 1982). The dormant hypnozoite may then remain this way for weeks to years, 
before it becomes active again and resumes schizogony. This delay in infection can result in 
clinical relapses of malaria. However, recent cases have documented that recrudescence can 
occur with clinical cases of P. falciparum infection (Foca et al., 2009; Greenwood et al., 




2008; Szmitko et al., 2009; Theunissen et al., 2009), and in in vitro studies (Thapar et al., 
2005), which would pose problems for current ongoing efforts to control and eradicate the 
disease. 
 
Figure 1. Life cycle of the Plasmodium parasite. Adapted from Suh et al., 2004. 
 
The mature schizont can contain 30,000 to 50,000 merozoites, and upon rupture of 
the hepatocyte, these merozoites are released into the bloodstream. The majority of the 
merozoites are ingested by Kupffer cells in the liver , but those that escape will rapidly invade 
red blood cells (erythrocytes), thus beginning the erythrocytic phase. The merozoite does not 
come into direct contact with the cytoplasm of the erythrocyte. Rather, it forms a 
parasitophorous vacuole (PV), where it will continue further development and maturation. 
In the PV, the merozoite will begin differentiating into a trophozoite, breaking down 
erythrocytic cytoplasmic components and using them as nutrients. The trophozoites will 
subsequently further mature into numerous merozoites, upon which the infected erythrocyte 
will rupture and release the merozoites into the bloodstream, thereby repeating the 




erythrocytic phase all over again. Such a cycle may take place several times in the human 
host.  
In addition to releasing the merozoites, the rupture of the erythrocyte will also release 
cellular debris. This cellular debris is toxic to the host, and in synchronous infection with high 
enough parasitemia, this results in a significant release of cytokines by the host, and is 
clinically manifested as fevers. The duration of the erythrocytic stages varies between species, 
resulting in the fevers being of tertian or quartan periodicity. 
Of the four Plasmodium species infecting humans, P. falciparum is the most life-
threatening, and is almost responsible for the reported deaths attributed to malaria. There are 
several clinical symptoms associated with severe malaria caused by P. falciparum, e.g. 
cerebral malaria (coma), metabolic acidosis, hypoglycaemia and severe anaemia. Infected 
erythrocytes display several modifications to their plasma membrane, the most notable being 
members of the P. falciparum Erythrocyte Membrane Protein-1 (PfEMP1) family. PfEMP1 
proteins are expressed on knob-like structures on the surface of the infected erythrocyte, and 
are responsible for binding to several different host vascular adhesins, such as CD36 and 
ICAM1. PfEMP1 also mediates binding of the infected erythrocyte to neighbouring 
uninfected erythrocytes, forming rosette structures. Rosetting has been hypothesized to 
increase the chances of a successful invasion of erythrocytes by merozoites. These properties 
allow the infected erythrocyte to sequester itself in the peripheral circulation and avoid 
splenic clearance (Kirchgatter and Del Portillo, 2005). Often, due to sequestration of such 
rosette structures in the vasculature, blood flow tends to be greatly decreased; binding of 
infected erythrocytes also causes a localised immune reaction, resulting in the release of 
cytokines and other mediators. This is particularly significant when it occurs in the cerebral 
vasculature (and is unique to P. falciparum infection), and can result in cerebral edema and 
permeabilization of the blood-brain barrier. This clinically manifests as cerebral malaria, and 
is a fatal complication of falciparum malaria (Warell and Gilles, Essential Malariology, 
2002). 




Upon erythrocytic invasion, a small fraction of the merozoites may not develop into 
trophozoites. Instead, they develop into non-multiplying sexual forms called gametocytes. 
These gametocytes are involved in the perpetuation of the life cycle of the parasite. When 
they are ingested by a feeding mosquito, they will reproduce sexually in the mosquito midgut, 
resulting in the production of sporozoites. These sporozoites will then travel to the salivary 
glands, where they will begin the entire life cycle anew (Suh et al., 2004; Warell and Gilles, 
Essential Malariology, 2002). 
 
1.1.2 The burden of malaria 
Approximately 90% of worldwide malaria deaths occur in sub-Saharan Africa, with 
the majority of these deaths being children under five years of age (World Health 
Organization, Africa Malaria Report 2003). The impact of malaria is mostly seen in children 
(Marsh et al., 1995), as their immune system is relatively naive and immature. The 
pathogenesis and morbidity of malaria results in low birth weights, improper nutrition and 
low attendance rates in schools. Children afflicted with malaria also suffer from learning 
disabilities and other neurological disorders (Holding and Snow, 2001; Kihara et al., 2006). 
Rising health costs and the loss of healthy labour causes widespread poverty and a lack of 
development in endemic countries (Gallup and Sachs, 2001; Sachs and Malaney, 2002). 
Malaria-endemic countries experience a larger-than-fivefold difference in gross domestic 
product than non-endemic countries, as well as slower economic growth (Sachs and Malaney, 
2002). Malaria is thus not just a medical disease in these countries, but a social and economic 
one as well.  
 
1.1.3 Drug resistance and targets 
Chloroquine was once the drug of choice for the treatment of malaria, but widespread 
misuse has resulted in growing resistance in the parasites, contributing to a global resurgence 
of malaria cases (White, 2004). To date, malaria has known resistance to all available drug 
classes, with the exception of artemisinins (White, 2004). Therefore, there is an urgent need 




for new drugs and drug targets, before the development of artemisinin resistance. One such 
attractive area for chemotherapy is pathways that unique to the parasite itself (Rosenthal et 
al., 2002). 
Cysteine proteases are important in various plasmodial process, the most critical 
among them being haemoglobin hydrolysis, erythrocyte invasion and rupture (Rosenthal et 
al., 2002; Rosenthal, 2004). Falcipains and SERAs are some of the types of cysteine proteases 
present in the parasite. Falcipains have been implicated in haemoglobin metabolism 
(Rosenthal, 2004), erythrocyte invasion and egress (Blackman, 2008; Greenbaum et al., 
2002), while SERAs are involved in erythrocyte rupture (Blackman, 2008). Cysteine 
proteases are thus attractive potential drug targets for chemotherapeutic intervention. 
 
 
1.2 Programmed cell death (PCD) 
In the 1970s, studies by Horvitz and Sulston on Caenorhabditis elegans revealed that 
out of the 1090 somatic cells that comprise the nematode, 131 of those cells will invariantly 
die. The process by which those cells die has been termed programmed cell death (PCD). 
 
Apoptosis is a form of PCD, with distinct morphological and bio-chemical 
characteristics. It is involved in a myriad of biological processes, such as embryonic 
development, tissue homeostasis, and the immune response (Fadeel and Orrenius, 2005; 
Luder et al., 2001). Consequently, too much or too little apoptosis can result in a variety of 
human diseases, which includes cancer and neuro-degenerative diseases (Bursch, 2004). 
Apoptosis is characterized by various changes such as externalization of phosphatidylserine, 
caspase activation, nucleus fragmentation, membrane blebbing, and formation of apoptotic 
bodies. This highly regulated process allows the organism to eliminate any unwanted cells 
without causing damage to the surrounding tissue (Bursch, 2004; Philchenkov, 2004). 
In contrast, necrosis as a cell death pathway is a more “violent” process, often 
resulting in cellular edema and leakage (Bröker et al., 2005). Often, necrosis is caused by 




damage to the plasma membrane (Philchenkov, 2004), and the release of cellular components 
often results in an inflammatory response (Bröker et al., 2005; Bursch, 2004). Unlike 
apoptosis, the cell does not play an active role in its own death. Recent evidence, however, 
has suggested that necrosis was not the accidental and uncontrollable process that it was once 
thought to be, but that it is an active and regulated process (Galluzzi and Kroemer, 2008; 
Henriquez et al., 2008; Hitomi et al., 2008). This phenomenon of programmed necrosis has 
been termed necroptosis. 




Table 1. Comparison of apoptosis, necrosis and paraptosis. Adapted from Sperandio et al., 2000. 
 




In recent years, other forms of PCD have been characterized. Autophagic PCD, or 
type II cell death, involves the digestion of cellular components by the endogenous lysosomal 
pathway (Bröker et al., 2005). This does not necessarily trigger cell death, but it allows the 
cell to adapt to changes in its environment (Bursch, 2004). It also allows the cell to maintain 
normal cellular turnover, by degrading proteins that are too old etc., as well as to function in 
cellular remodelling (Bröker et al., 2005). The critical role of the lysosomal vacuoles 
distinguishes autophagic cell death from apoptosis, or type I cell death, where the lysosomes 
are only involved much later in the death process (Bursch et al., 2000). In addition to cell 
death, autophagy has also been implicated in lifespan regulation (Dwivedi and Ahnn, 2009). 
An alternative form of cell death, paraptosis, is a non-apoptotic form of PCD, i.e. it 
does not display the typical characteristics of apoptosis. In addition to lacking the expected 
apoptotic characteristics, cells undergoing paraptosis display cytoplasmic vacuolation 
(Sperandio et al., 2000) and swelling of the mitochondria and endoplasmic reticulum (ER) 
(Bröker et al., 2005). 
Pyroptosis is another kind of cell death, and its features include a significant increase 
in the size of the cell, rapid loss of plasma membrane integrity, and release of 
proinflammatory intracellular constituents (Bergsbaken et al., 2009). In that respect, the 
morphological features are practically indistinguishable from necrosis. Pyroptosis, however, 
also demonstrates hallmarks of apoptosis, such as DNA cleavage and dismantling of the actin 
cytoskeleton (Bergsbaken et al., 2009). The molecular mediator (caspase 1) of pyroptosis is 
also involved in the apoptotic pathway (Bergsbaken et al., 2009; Galluzzi and Kroemer, 2009; 
Suzuki et al., 2007), further blurring the lines between apoptosis, necrosis and programmed 
necrosis. 
 
1.3 Molecular mediators of PCD 
As described above, there are several different types of PCD. However, these types of 
cell death may have overlapping characteristics, and are therefore not mutually exclusive 
(Bröker et al., 2005; Lockshin and Zakeri, 2002; Zakeri et al., 1995). The different cell death 




programs also share many common signalling pathways (Bröker et al., 2005), and it may be 
necessary to recognize that a whole continuous spectrum of types of cell death exists (Bursch, 
2004; Lockshin and Zakeri, 2002). For the purpose of this thesis, apoptotic markers, such as 
DNA damage and externalization of phosphatidylserine on the plasma membrane, will be 
used to investigate cell death. 
 
1.3.1 Metazoa 
Apoptosis has been extensively studied in a variety of multicellular eukaryotic 
organisms (metazoans), from C. elegans (where it was first characterized) to humans and 
insects (Drosophila). 
The first step in understanding the molecular processes involved in apoptosis came 
when it was discovered that the C. elegans ced-3 gene is a homologue of the interleukin-1β 
processing enzyme (ICE) in humans (Yuan et al., 1993); subsequent overexpression of ICE in 
mammalian cells induced apoptosis (Miura et al., 1993). ICE was later renamed caspase-1, 
and currently, more than ten mammalian caspases have been discovered since then (Fan et al., 
2005; Li and Yuan, 2008; Yi and Yuan, 2009). 
Caspases are so-named because of its unique mechanistic action: a critical conserved 
cysteine residue is required for proteolysis, and protein substrates are always cleaved after an 
aspartate residue. Hence, cysteine-dependent aspartate specific protease (Timmer and 
Salvesen, 2007). In addition, a histidine residue further upstream is required for activation of 
the critical cysteine residue (Degterev et al., 2003). These two critical residues have been 
termed the catalytic dyad. 
Caspases belong to clan CD, family C14 of the cysteine protease superfamily 
(Timmer and Salvesen, 2007), and they all share several common features (Degterev et al., 
2003). All caspases possess a conserved pentapeptide sequence at their active site, QACXG. 
This does not translate into substrate specificities – different caspases have different optimal 
substrate specificities, and can be grouped as such (Degterev et al., 2003; Grütter, 2000). 






Figure 2. Grouping of caspases.  
Caspases can be grouped according to A. their substrate specificities (Grütter, 2000) or B. the length of their 
prodomains (Li and Yuan, 2008). 
 




All caspases are synthesized as zymogens (or procaspases), and each caspase 
molecule contains 4 domains: a prodomain of variable length, a p20 subunit, a p10 subunit, 
and a linker connecting the p20 and p10 subunits (Degterev et al., 2003; Philchenkov, 2004), 
although the linker is not present in certain caspases (Philchenkov, 2004). Activation of 
caspases occur when the prodomain is removed, followed by the proteolytic cleavage of the 
remainder protein into the two respective subunits. Two p20 and two p10 subunits will then 
oligomerize and form a heterotetramer, the enzymatically-active form of caspases (Fan et al., 
2005; Grimm, Genetics of Apoptosis, 2003; Grütter, 2000; Philchenkov, 2004). 
Caspases can be further divided into two groups based on the length of their 
prodomains. Caspases which possess a long prodomain are generally known as initiator 
caspases (Grimm, Genetics of Apoptosis, 2003; Li and Yuan, 2008; Philchenkov, 2004). The 
prodomains of caspases contain protein interaction domains, such as the caspase recruitment 
domain (CARD) and death effector domain (DED), which recruit the procaspases to specific 
complexes upon activation of upstream signals. This results in activation of the caspases via 
autocatalysis; activated initiator caspases can also cleave other precursors of itself in a 
positive feedback loop. The activated initiator caspases will then activate its downstream 
targets, usually the effector caspases. In certain cases, initiator caspases can also act as 
effector caspases, thereby amplifying the cell death signal (Philchenkov, 2004). 
Effector caspases do not possess a long prodomain, and require cleavage by other 
proteases before they can be activated (Grimm, Genetics of Apoptosis, 2003). Besides initiator 
caspases, other non-caspase proteases such as cathepsins and calpains can also activate 
effector caspases (Philchenkov, 2004). Effector caspases, as the name suggests, are 
responsible for most of the cellular dismantling that is observed during apoptosis (Li and 
Yuan, 2008). 
Caspases can be activated by either one of two pathways. The extrinsic pathway 
relies on receptors in the plasma membrane, and upon ligand binding, e.g. FAS and TNFα, 
the bound receptors oligomerize. This recruits adaptor proteins and procaspase, forming a 
protein complex, which activates the caspases. The activated caspases are subsequently 




released into the cytoplasm, where they will activate downstream effector molecules, which 
will ultimately lead to cell death (Degterev et al., 2003; Fadeel and Orrenius, 2005; Fan et al., 
2005; Grimm, Genetics of Apoptosis, 2003; Philchenkov, 2004). 
In the intrinsic pathway, the mitochondria play a pivotal role. Under normal 
physiological conditions, there is a delicate balance of pro- and anti-apoptotic molecules 
(Grimm, Genetics of Apoptosis, 2003; Huang, 2002), which are members of the Bcl-2 family 
of proteins (Grimm, Genetics of Apoptosis, 2003). Depending on the stimuli received by the 
cell, apoptosis may be initiated or attenuated. When the cell is stressed by UV-induced DNA 
damage or reactive oxygen species (ROS) etc., the outer membrane of the mitochondria 
permeabilizes, releasing a range of proteins from the intermembrane space (Grimm, Genetics 
of Apoptosis, 2003). Proteins released include cytochrome c, apoptosis-inducing factor (AIF) 
and endonuclease G. The presence of cytochrome c in the cytoplasm will induce the 
formation of a protein complex called the apoptosome, which consists of Apaf-1, cytochrome 
c, dATPs and procaspase-9. Procaspase-9 is then processed into its active form, which will 
then proceed to activate downstream caspases (Grimm, Genetics of Apoptosis, 2003; Li and 
Yuan, 2008). 
 
1.3.2 Protozoa (including Plasmodium spp.) 
Apoptosis has been studied exhaustively in metazoans, as the altruistic nature of PCD 
suggests an obvious benefit for multicellular organisms. The idea that PCD could exist in 
unicellular organisms, such as bacteria and protozoan (unicellular eukaryotes), seemed 
illogical and counter-intuitive – there seems to be no reason at all why an individual cell 
would commit suicide. 
However, certain unicellular eukaryotes have been observed to display features which 
are normally associated with apoptosis in metazoans. These organisms include Trypanosoma 
(Ameisen et al., 1995; Piacenza et al., 2001; Ridgley et al., 1999; Welburn et al., 1996), 
Leishmania (Arnoult et al., 2002; Das et al., 2001; Lee et al., 2002; Moreira et al., 1996), 
Plasmodium (Al-Olayan et al., 2002; Deponte and Becker, 2004; Hurd and Carter, 2004; 




Hurd et al., 2006; Le Chat et al., 2007; Meslin et al., 2007; Picot et al., 1997), the slime mold 
Dictyostelium discoideum (Cornillon et al., 1994), the ciliate Tetrahymena thermophila 
(Christensen et al., 1995), the dinoflagellate Peridinium gatunense (Vardi et al., 1999), the 
intestinal protozoan parasite Blastocystis (Nasirudeen et al., 2001a, 2001b, 2004; Nasirudeen 
and Tan, 2004, 2005; Tan et al., 2001; Tan and Nasirudeen, 2005) and Saccharomyces 
cerevisiae (Granot et al., 2003; Ludovico et al., 2001; Madeo et al., 1997, 1999, 2004). 
Several reasons have been postulated to explain cell death in unicellular organisms. 
One proposes that cell death is an altruistic response, and that certain cells, such as those 
which produce a large amount of reactive oxygen species, will die preferentially. This 
conserves limited resources, and benefits the entire population (Hurd and Carter, 2004). In 
parasites, cell death would also serve as a mechanism for limiting the population size, to 
allow for successful transmission (Al-Olayan et al., 2002; Das et al., 2001; Hurd and Carter, 
2004). A lower parasite load would also limit the intensity of infection and allow for a higher 
host survival rate. 
Although markers of apoptosis have been observed and characterized in protozoan, 
no molecular mediators homologous to those found in metazoans were found until recently, 
such as when endonuclease G was found to be involved in trypanosome cell death 
(Gannavaram et al., 2008). Indeed, the absence of caspases, which play a major and important 
role in metazoan apoptosis, was a great obstacle to proving that a conserved pathway exists in 
both metazoans and protozoan (Madeo et al., 2002), even though heterologous expression of 
Bax (a metazoan pro-apoptotic mediator) was shown to be lethal to S. cerevisiae (Greenhalf et 
al., 1996; Ligr et al., 1998; Madeo et al., 1999; Manon et al., 1997). Conversely, heterologous 
expression of the metazoan anti-apoptotic mediators Bcl-2 and Bcl-xL increases the survival 
rate of senescent yeast cells (Longo et al., 1997) and those which have been exposed to H2O2 
(Chen et al., 2003). Overexpression of Bcl-xL also rescued yeast cells which co-
overexpressed Bax, preventing the appearance of apoptotic features (Greenhalf et al., 1996; 
Ligr et al., 1998; Manon et al., 1997). Taken together with the fact that no homologs of Bax, 
or other members of the Bcl-2 family (Priault et al., 2003), have been identified in the yeast 




genome, these observations suggest that the apoptotic machinery may be conserved between 
unicellular and multicellular eukaryotes (Greenhalf et al., 1996). 
In 2000, Uren et al. identified two families of caspase-like proteins using iterative 
PSI-BLAST searches (Uren et al., 2000). Paracaspases are found in metazoans and 
Dictyostelium, while metacaspases are found in plants, fungi and protozoa. Alignment of the 
novel sequences with classical caspases showed that the conserved cysteine and histidine 
residues are both present in paracaspases and metacaspases.  
Depending on the tertiary structure and sequence similarity, metacaspases can be 
divided into two classes. Type I metacaspases are generally found in plants and fungi, and 
they contain prodomains with a proline-rich repeat motif. In the case of plant type I 
metacaspases, they may also possess a zinc finger motif. Type II metacapases typically do not 
Figure 3. Domains of caspases, paracaspases and metacaspases. All possess the 
conserved histidine and cysteine residues required for catalytic action (Uren et 
al., 2000) 




possess any prodomains; however, they have a 200 residues insertion located C-terminally of 
their catalytic domain. 
Following the discovery of metacaspases, a metacaspase YCA1 was found to be 
involved in yeast apoptosis. YCA1 undergoes a cleavage pattern similar to classical caspases, 
and is activated when yeast is exposed to apoptotic stimuli. In addition, a YCA1 knockout 
yeast strain increases resistance to apoptosis caused by H2O2 or senescence. Conversely, 
overexpression of YCA1 leads to increased sensitivity to apoptosis-inducing stimuli (Madeo 
et al., 2002). 
In addition, metacaspases from other organisms, such as Trypanosoma (Szallies et al., 
2002), Leishmania (González et al., 2007), Candida (Cao et al., 2009), the fission yeast 
Schizosaccharomyces pombe (Lim et al., 2007), the Norway spruce Picea abies (Bozhkov et 
al., 2005), and Arabidopsis thaliana (Watanabe and Lam, 2005), demonstrated a similar 
function, thus further adding weight to the idea of a conserved apoptotic pathway between 
protozoans and metazoans. 
Despite the apparent functional similarity, metacaspases differ from traditional 
caspases in certain ways. Unlike caspases, which requires an aspartate residue at the substrate 
P1 position, initial 3D modeling showed that metacaspases prefer uncharged residues at that 
position (Uren et al., 2000). However, it appears from work done on Arabidopsis 
(Vercammen et al., 2004; Watanabe and Lam, 2005), Trypanosoma (Moss et al., 2007) and 
Leishmania (González et al., 2007; Lee et al.,2007) metacaspases that they prefer basic 
residues, namely arginine or lysine, at the P1 position. The change in amino acid preference 
may be a reason why metacaspases are insensitive to caspase-specific molecules, such as 
substrate peptides and inhibitors, but are sensitive to serine protease inhibitors (Bozhkov et 
al., 2005; Vercammen et al., 2004; Watanabe and Lam, 2005). Thus, while caspase-like 
activities have been reported in organisms possessing metacaspases (Al-Olayan et al., 2002; 
Bozhkov et al., 2004; Das et al., 2001; Hoeberichts and Woltering, 2003; Kosec et al., 2006; 
Lam and del Pozo, 2000; Lee et al., 2002; Madeo et al., 2002, 2004; Thrane et al., 2004), it 




would seem that metacaspases are not responsible for such activities, even though they appear 
to be involved in the apoptotic machinery. 
 
1.4 Objectives of study 
Proteases of parasitic protozoa, particularly cysteine proteases, are attractive targets 
for chemotherapy, as they play key roles in various biological processes, from invasion of 
host cells, to pathogenesis (Mottram et al., 2003; Rosenthal et al., 2002; Rosenthal 2004; Wu 
et al., 2003). In the case of a debilitating disease such as malaria, resistance to conventional 
drugs are becoming increasingly more common (Rosenthal et al., 2002; Rosenthal 2004; Wu 
et al., 2003), and it is more necessary than ever to discover new drug targets that might aid in 
the control, if not eradication, of this disease.  
As described above, metacaspases have been implicated in apoptosis in a variety of 
protozoa that lacks classical caspases. S. cerevisiae has traditionally been used as a model 
organism to study various cellular processes (Fröhlich et al., 2007), and the ease of 
manipulation and many readily-available established protocols makes the yeast model system 
an excellent candidate for studying Plasmodium metacaspases. The yeast metacaspase YCA1 
has been characterized, and wild-type and YCA1-knockout strains are readily available. In P. 
falciparum itself, three putative metacaspase genes have been identified (Le Chat et al., 
2007). A BLAST search revealed that one of them, PfMCA1 (PlasmoDB gene ID 
PF13_0289), bears 42% similarity to YCA1, making PfMCA1 a good candidate for studying 
the functional role of metacaspases in P. falciparum apoptosis.  
The first objective of this study would be to clone the PfMCA1 gene into both wild-
type and YCA1-knockout yeast. The functional effect of PfMCA1 expression, with regards to 
cell death, will be investigated. If PfMCA1 has a function similar to YCA1, it should increase 
sensitivity to cell death stimuli. 
The second objective would be to engineer epitope tags into the PfMCA1 protein to 
allow for affinity purification. Purified PfMCA1 can be used to study its characteristics, such 




as its enzyme kinetics, substrate and inhibitor specificity. Hopefully, understanding its 
biochemical characteristics would provide targets for drug intervention. 




2. MATERIALS & METHODS 
 
2.1 Plasmodium falciparum 
2.1.1 Laboratory culture 
In vitro culture of P. falciparum strain 3D7 was cultured in RPMI media 
supplemented with 0.5% (w/v) Albumax II (Gibco), 2 mM L-glutamine (Sigma-Aldrich), 
0.005% (w/v) hypoxanthine (Sigma-Aldrich) and 10 mg/L of gentamycin (Gibco), at 37oC, 
and gassed with a nitrogen-balanced air mixture containing 5% O2 and 5% CO2. Haemotocrit 
was maintained at 2.5% and parasitemia was never allowed to rise beyond 15%. Culture 
medium was changed every two days.  
To monitor the culture, a thin blood smear was prepared on a microscope glass slide. 
The culture flask was shaken gently to homogenise the culture, and a 100 µl aliquot was taken 
for the smear. The aliquot was centrifuged briefly to pellet the erythrocytes, and the 
supernatant was removed. The pellet was resuspended in the residual supernatant, and the 
resuspension was smeared onto the glass slide. The smear was allowed to air-dry, and 
methanol was used for fixation. The fixed smear was then treated with Giemsa stain for 15 
minutes, after which any excess stain was washed off with tap water. The smear was then 
blot-dried, and viewed under a conventional optical microscope.  
2.1.2 Isolation of genomic DNA 
Genomic DNA was extracted from infected erythrocytes following a protocol from 
Methods in Malaria Research (Ljungström et al., 2004). Briefly, 10 ml of parasite culture 
(10% parasitemia) was centrifuged at 3,000g for 2 minutes. The supernatant was discarded, 
and the cell pellet was washed once with cold PBS. The infected erythrocytes were 
resuspended in 1 ml of PBS and 10 µl of 5% saponin was added. Upon observation of 
clarification (complete erythrocytic lysis), the mixture was centrifuged at 6,000g for 5 
minutes. 25 µl of lysis buffer (40 mM Tris-HCl (pH 8.0), 80 mM EDTA, 2% SDS, 25 µg/ml 
proteinase K, 10 U/ml RNase) and 75 µl of distilled water was added to resuspend the pellet, 




and the mixture incubated at 37oC for 3 hours. Phenol-chloroform-isoamyl alcohol (25:24:1) 
(Sigma-Aldrich) was used to purify the genomic DNA.The aqueous layer was recovered, and 
used for another round of phenol-chloroform extraction. Any residual phenol remaining in the 
aqueous layer was removed by a wash step with chloroform. The genomic DNA was 
precipitated from the aqueous layer by adding 0.1 volume of sodium acetate and 2.5 volumes 
of absolute ethanol. The mixture was incubated at -20oC for an hour, before centrifugation at 
2,000g for 30 minutes at 4oC. The DNA pellet was washed once with 70% ethanol, 
centrifuged at 2,000g for 30 minutes at 4oC, and air-dried. The dried DNA pellet was then 
resuspended in 50 µl of sterile deionised water. 
2.1.3 Isolation of P. falciparum total RNA 
P. falciparum strain 3D7 cultures were grown to high parasitemia (15-20%), and pure 
parasites were obtained via saponin lysis of erythrocytes (as described previously in section 
2.1.2). 1 ml of TRIzol (Invitrogen) was added to the cell pellet and transferred to a 1.5 ml 
tube after homogenising. 10 µl of Triton X-100 was added to the sample, and sonication was 
used to lyse the parasites. 200 µl of chloroform was added, and the mixture was vortexed 
vigorously for 30 seconds. The mixture was then centrifuged at maximum speed for 5 minutes 
in a table-top microcentrifuge. The aqueous layer was transferred to a new tube and 400 µl of 
ice-cold isopropanol was added. The RNA was allowed to precipitate by incubating the 
mixture at -20oC for 2 hours. The precipitated RNA was then pelleted by centrifugation at 
maximum speed in a microcentrifuge for 15 minutes at 4oC. The supernatant was removed, 
and the RNA pellet was washed with 70% ethanol prepared with DEPC 
(diethylpyrocarbonate)-treated water. The washed pellet was air-dried, and the RNA was 
resolubilized in 50 µl of sterile DEPC-treated water (Invitrogen).  
2.1.4 Quantification of P. falciparum total RNA 
The concentration of RNA was determined spectrophotometrically using the 
NanoDrop® ND-1000 Spectrophotometer (Nanodrop Technologies Inc.), and its associated 
computer program at the RNA-40 setting. 2 µl of the RNA sample was used per 
measurement. In addition, the ratio of the absorbance at 260 nm to the absorbance at 280 nm 




was used to determine the purity of the RNA. Pure RNA has a ratio of 1.7 to 2.1 (Applied 
Biosystems TechNotes,  Critical Parameters for Successful RNA Amplification), and the 
values obtained from samples typically fall within this range. 
2.1.5 Preparation of P. falciparum cDNA 
P. falciparum total RNA was treated with DnaseI (Promega) according to 
manufacturer’s instructions.  100 ng of the Dnase-treated total RNA was then used for first-
strand cDNA synthesis using the RevertAidTM H-minus M-MuLV reverse transcriptase from 
Fermentas (according to the manufacturer’s protocol), and oligo-dT primers. The reaction 
mixture was incubated for 60 minutes at 42oC. 4µl of the mixture was then used for PCR. 
2.1.6 PCR amplification of metacaspase gene PfMCA1 
The following primers were used to amplify the PfMCA1 gene from P. falciparum 
genomic DNA: 5’PfMCA-EcoRI (GCCGAATTCATGGAAAAAATATACGTCAAAAT) 
and 3’PfMCA-SalI (GGGCGTCGACTAAAAAAAAAATAAATTTTTAAGTTC), with the 
EcoRI and SalI restriction sites underlined respectively. Subsequently, the reverse primer was 
modified to include a hexahistidine tag at the C-terminus of the PfMCA1 protein: 3'-PfMCA-
6×His-SalI (GGCGTCGACTAGTGATGATGGTGATGATGAAAAAAAAATAAATT-
TTTAAGTTC). The SalI restriction site is underlined, while the nucleotide sequence for the 
hexahistidine tag are in bold. EcoRI and SalI restriction sites were used for unidirectional 
cloning into the yeast shuttle plasmid vector PactTHA423. 
PCR was performed using the Expand High Fidelity PCR kit (Roche) using the 
following conditions: initial denaturation was carried out at 95oC for 1 minute; 5 cycles of 
denaturation at 95oC for 1 minute, annealing at 51oC for 1 minute, and elongation at 72oC for 
2 minutes; an additional 25 cycles of denaturation at 95oC for 1 minute, annealing at 51oC for 
1 minute, and elongation at 72oC for 2 minutes, with the duration for the elongation step 








2.1.7 Optimization of PfMCA1 for yeast expression 
The coding sequence for PfMCA1 was optimized for protein expression in S. 
cerevisiae by reverse-translating the PfMCA1 protein sequence to a codon-optimized 
nucleotide sequence. The optimized coding sequence was synthesized by a commercial 
vendor (Genscript, Piscataway, NJ), and included a hexahistidine tag after the start codon. 
2.1.8 PCR amplification of yeast-optimized PfMCA1 
The larger-than-average size (2.3 kilo base-pairs) of P. falciparum genes (Gardner et 
al., 2002), and its high (A+T)-content pose significant obstacles to successful gene expression 
(Withers-Martinez et al., 1999; Yadava and Ockenhouse, 2003; Zhang et al., 2002). To 
increase the level of protein expression, a PfMCA coding sequence optimized for yeast 
expression was generated by incorporating a yeast codon bias and decreasing the (A+T)-
content. The optimized DNA sequence of PfMCA1 was amplified by using the following 
primers: OpPfMCA-fw (GCCGAATTCATGCACCACCATC) and OpPfMCA-rv 
(TATAGCGGCCGCGAAGAAAAATAAATTC). The EcoRI and NotI restriction sites are 
underlined respectively. A forward primer OpPfMCA-noHis-fw (GCCGAATTCATGGAGA-
AAATTTATGTCAAG) which amplifies the PfMCA1 gene without the hexahistidine tag was 
also used, in situations where the hexahistidine tag was not required. 
PCR conditions were the same as that described above in section 2.1.6. 
2.1.9 Site-directed mutagenesis of PfMCA1 
The catalytic domain possesses two critical residues, a histidine at position 404, and a 
cysteine residue at position 460. In order to replace the critical cysteine residue with alanine, a 
set of primers, OpPfMCA-C460A-fw (GCTGTTGTAGATTCGGCTAATAGCGGTTCTTC) 
and OpPfMCA-C460A-rv (GAAGAACCGCTATTAGCCGAATCTACAACAGC) primers 
containing the mutation (C460A) were designed. These primers are reverse complements of 
each other. 
The forward primer for the PfMCA1 gene (OpPfMCA-noHis-fw), was used with the 
reverse primer containing the mutation (OpPfMCA-C460A-rv), while the reverse primer for 
the PfMCA1 gene (OpPfMCA-rv) was used together with the forward primer containing the 




mutation (OpPfMCA-C460A-fw), to generate two sets of PCR products. The PCR products 
were purified using the PCR Purification Kit (QIAgen) according to manufacturer’s 
instructions. A second round of PCR was carried out using the purified products themselves 
as primers. The full-length gene containing the mutation was then purified via gel 
electrophoresis using a 2.0% (w/v) agarose gel (QIAgen Gel Purification Kit), and verified 
via DNA sequencing. 
The PCR conditions used were the same as that described above for the amplification 
of PfMCA1 (section 2.1.6). 
2.1.10 Molecular cloning and screening 
After purification of the desired PCR fragments, they were digested with the 
appropriate restriction enzymes. The digestion reactions were carried out overnight at 37oC. 
In order to minimize STAR activity (unspecific digestion) while ensuring most of the PCR 
fragments were digested, as little restriction enzyme as possible was used. Typically, 1 unit of 
restriction enzyme was added to a 60 µl reaction volume. 
After digestion, the digested PCR products were purified with the QIAgen PCR 
Purification Kit. They were then ligated with the plasmid vector, which had been digested 
with the same restriction enzymes, using T4 DNA ligase (New England Biolabs), following 
manufacturer’s instructions. In addition, the plasmid vector had been treated with Antarctic 
Phosphatase (New England Biolabs), as per manufacturer’s instructions, after restriction 
enzyme digestion to prevent re-circularization. The ligation was carried out overnight at room 
temperature. 
Competent E. coli cells were added to the ligation mix for transformation, and 
positive colonies were screened, as described below in section 2.2.4.  
2.1.11 DNA sequencing 
As PfMCA1 is a large gene (1,842 base-pairs), several sequencing primers needed to 
be designed in order to accurately sequence the entire gene. Sequencing was done both in the 
5’→3’ and 3’→5’ directions, and started from the regions flanking the multiple cloning site 
(approximately 100-200 base-pairs upstream/downstream). However, the entire gene was not 




sequenced completely in either direction. Instead, each would only sequence approximately 
60% of the gene, and there would be a region of overlap in the middle portion. In addition, 
sequencing primers were set approximately 400 base-pairs apart, to provide some degree of 
continuity between consecutive primers. 
DNA sequencing was carried out using the BigDye® Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems), and using a modified manufacturer’s protocol. Briefly, 
water was added to the reaction mixture containing 3 µl of the Ready Reaction Mix, 3 µl of 
5× Sequencing Buffer, 3.2 pmol of primers and 2 µl of DNA template, to a total volume of 15 
µl. The PCR was carried out using the following parameters: an initial denaturation cycle at 
96oC for 1 minute; 25 cycles of denaturation at 96oC for 10 seconds, annealing at 50oC for 5 
seconds, and elongation at 60oC for 4 minutes; and a final holding step at 16oC. The thermal 
ramp rate was set at 1oC/s. 
The products were purified using the ethanol/EDTA precipitation method, as 
recommended by Applied Biosystems. Briefly, 5 µl of 125 mM EDTA was added to the 
sequencing mix, followed by 60 µl of absolute ethanol. The mixture was mixed by gentle 
pipetting, transferred to a 1.5 ml eppendorf tube, and incubated at room temperature for 15 
minutes. After incubation, the mixture was centrifuged at 3,000g for 32 minutes at 4oC. The 
supernatant was carefully removed, and the DNA pellet was washed with 60 µl of 70% 
ethanol. The mixture was further centrifuged at 2,000g for 15 minutes at 4oC, and the 
supernatant carefully removed. The pellet was then dried at 50oC in a heat block. The dry 
pellet was then sent for reading by the ABI PRISM® 3100 Genetic Analyzer. 
 





Table 2. List of sequencing primers used for the various clones of PfMCA1. The original sequence of PfMCA1 
was used for the plasmid vectors PactTHA423 and Pgal1-HA-PL-Tactin-423. As the sequence used is the same, the 
first and last sequencing primer was changed according to the plasmid vector. The optimized PfMCA1 sequence 




2.1.12 SEG analysis of PfMCA1 
Regions of low complexity are regions in the protein sequence where there is a 
periodic repetition of certain amino residues, and can hinder the successful expression of a 
gene (Birkholtz et al., 2008). The protein sequence of PfMCA1 was entered into an online 
SEG program (http://mendel.imp.ac.at/METHODS/seg.server.html) to determine the low 
complexity regions that are present. The parameters used were the same as that employed by 
Pizzi & Frontali (2001): window length: 45; trigger complexity: 3.4; extension complexity: 
3.75.   
 
2.2 E. coli 
2.2.1 Bacterial strains and culture 
E. coli strain DH5α cells were used for amplification of recombinant plasmids, and E. 
coli strain BL21 (DE3) cells were used for protein expression and purification. 

























All strains were grown in Luria-Bertani (LB) broth (1% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 1% (w/v) NaCl), and in the case of transformed bacterial cells, with the 
presence of 100 µg/ml ampicillin. Bacterial cells were grown at 37oC, 220 rpm in a shaking 
incubator. 
2.2.2 Plasmids 
The pGEX vector plasmid (Amersham Biosciences) was used for heterologous 
protein expression in E. coli. The strain of pGEX used was pGEX-4T-1, which allowed in-
frame cloning with the EcoRI restriction site at the 5’-end of the gene sequence. Protein 
expression can be controlled with the presence of isopropyl β-D-1-thiogalactopyranoside 
(IPTG) – presence of IPTG will induce protein expression.  
2.2.3 Molecular cloning 
Molecular cloning of desired gene fragments into the pGEX vector was carried out as 
described in section 2.1.10. The restriction enzyme sites used are EcoRI at the 5’-end and 
NotI at the 3’-end. 
2.2.4 Preparation of competent E. coli cells 
An overnight 2 ml bacterial culture was diluted in 125 ml of LB medium, and 
incubated at 37oC for 2 hours. The culture was then centrifuged at 2,000 rpm for 10 minutes, 
and the supernatant was removed. The cell pellet was kept on ice for 10 minutes, after which 
it was resuspended in 40 ml of CCMB medium (80 mM CaCl2, 20 mM MnCl2, 10 mM 
MgCl2, 10 mM KCl, 10% glycerol (v/v), pH 6.4), and kept on ice for 20 minutes. The cell 
suspension was then centrifuged again at 2,000 rpm for 10 minutes, and the cell pellet was 
resuspended in 10 ml of fresh CCMB medium. The cell suspension was then aliquoted and 
flash-frozen in liquid nitrogen before being kept at -80oC. 
2.2.5 Transformation and screening 
40 µl of the competent cells was added to the plasmid solution. This mixture was 
homogenised gently, and incubated on ice for 20 minutes. The mixture was then heat-shocked 
at 42oC for 90 seconds, after which 100 µl of LB medium was added. This mixture was 
incubated at 37oC for 1 hour before it was plated on LB agar plates containing 100 µg/ml 




ampicillin. As all the plasmid vectors used used ampicillin as a bacterial selection marker, 
agar plates used for bacterial cultivation contained ampicillin. The agar plates were incubated 
at 37oC overnight, and observed for colony growth the next day. 
Colonies were screened using colony PCR. Picked colonies were inoculated into 1 ml 
of LB broth containing 100 µg/ml of ampicillin, and incubated at 37oC, with shaking at 220 
rpm for 1 hour. 1 µl of the inoculated broth was added to 49 µl of PCR reaction mix 
containing a forward primer specific for the promotor in the plasmid vector, and a reverse 
primer specific for the cloned gene. This ensured that the gene was cloned correctly and is in 
the correct orientation. 4 ml of LB broth with ampicillin was then added to cultures which 
gave a positive band of the correct size, and incubated overnight. Overnight cultures were 
then used for plasmid isolation using the QIAprep Spin Miniprep Kit (QIAgen), following 
manufacturer’s instructions. 
2.2.6 DNA sequencing 
The following pGEX sequencing primers were used to sequence the cloned gene: 
pGEX-fw (GGGCTGGCAAGCCACGTTTGGTG) and pGEX-rv (CCGGGAGCTGCATGT-
GTCAGAGG). 
Sequencing was carried out as described in section 2.1.11. 
 
2.2.7 Induction of protein expression 
1 ml of E. coli strain BL21 (DE3) transformed with the appropriate plasmid was 
grown overnight in LB broth in the presence of ampicillin at 37oC and shaking at 220 rpm. A 
100 µl aliquot of the overnight culture was added to 1 ml of fresh LB broth with ampicillin. 
The freshly-inoculated cultures were then incubated with shaking for 3-5 hours at room 
temperature, before the addition of IPTG to a final concentration of 1 mM. The cultures were 
further incubated for an additional hour before the bacterial cells were harvested. 
2.2.8 Isolation of bacterial protein extracts 
Cultures were centrifuged at 1,000g for 10 minutes, and the supernatant was 
discarded. The cell pellet resuspended in 200 µl of ice-cold PBS buffer, and the resuspension 




was sonicated. Lysis was deemed complete when the resuspension became translucent. The 
total cell lysate was centrifuged at 13,000 rpm, and 5 µl of the supernatant was used for SDS-
PAGE. 
2.2.9 Immunoblotting 
The protein sample was mixed with an equal volume of Laemmli sample buffer (Bio-
Rad) as per manufacturer’s instructions, and boiled at 100oC for 5 minutes. The mixture was 
then electrophorectically separated on a 12% SDS-PAGE gel running at 100V for 1 hour 
using the Mini-PROTEAN® 3 Cell (Bio-Rad). The gel was then equilibrated in Towbin 
transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3) for 15 minutes before 
being electrophorectically transferred to a nitrocellulose membrane at 20V for 30 minutes 
using the Trans-Blot® Semi-Dry Electrophoretic Transfer Cell (Bio-Rad). The membrane 
blot was then blocked with PBST (PBS, 0.1%(v/v) Tween 20) solution containing 5% nonfat 
milk for 1 hour. After washing with PBST, the blocked membrane blot was incubated with 
PBST containing the primary antibody and 1% nonfat milk for 1 hour. The membrane was 
washed twice with PBST, with each wash taking 5 minutes. The membrane was subsequently 
incubated with PBST containing the horseradish peroxidase-conjugated secondary antibody 
and 1% nonfat milk for an hour. The washing was performed as described previously. The 
membrane was treated with the ECL Plus Western Blotting Detection Reagents (GE 
Lifesciences) as per manufacturer’s instructions. The treated membrane was then exposed to 
X-ray film for visualization. 
 
2.3 S. cerevisiae 
2.3.1 Yeast strains and culture 
Two yeast strains BY4741 (MATa; his3∆1; leu2∆0; met15∆0; ura3∆0) and a YCA1 
disruptant (MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; YOR197w::kanMX4) were kindly 
provided by Dr Norbert Lehming (University of Singapore, Singapore). These two strains 
were used as hosts for transformation. 




Yeast cells were incubated at 30oC, and liquid cultures were shaken at 220 rpm. Fresh 
cultures of host strains were used for each set of transformation, by streaking out from stocks 
stored at -80oC, and then rendering the streaked yeast cells competent for transformation. 
2.3.2 Yeast shuttle plasmid vectors 
Three yeast shuttle vectors were used, PactTHA423, Pgal1-HA-PL-Tactin-423, and 
pESC-HIS (Stratagene). Both PactTHA423 and Pgal1-HA-PL-Tactin-423 were kindly 
provided by Dr Norbert Lehming (National University of Singapore, Singapore). 
PactTHA423 possesses the actin promotor-terminator cassette, resulting in constitutive 
protein expression. Pgal1-HA-PL-Tactin-423, on the other hand, possesses a Gal1 promotor, 
and protein expression is only induced in the presence of galactose. Both PactTHA423 and 
Pgal1-HA-PL-Tactin-423 will produce fusion proteins with a haemagluttin (HA) tag at the C-
terminus. pESC-HIS contains an galactose-inducible promotor as well, and results in a fusion 
protein with a FLAG tag at the C-terminus. All three plasmids contain the ampicillin 
resistance gene for selection in bacteria and the HIS3 auxotrophic selection marker (yeast 
cells that have been successfully transformed with these plasmids are able to grow in 
histidine-deficient media). 
For generation of HA-tagged fusion proteins using PactTHA423 and Pgal1-HA-PL-
Tactin-423 plasmid vectors, PCR primers were designed to include an EcoRI restriction site 
at the 5’-end, and a SalI restriction site at the 3’-end of the PCR product. Similarly, generation 
of FLAG-tagged proteins using the pESC-HIS plasmid vector required PCR primers which 
incorporated an EcoRI restriction site at the 5’-end and a NotI restriction site at the 3’-end of 
the PCR product.  
2.3.3 Isolation of yeast genomic DNA 
Genomic DNA from wild-type S. cerevisiae strain BY4741 was obtained using the 
protocol of Harju et. al (2004). Briefly, a yeast colony was cultured overnight in 5 ml of 
YPDA medium. A 1.5 ml aliquot was centrifuged at maximum speed in a table-top micro-
centrifuge for 5 minutes. The cell pellet was resuspended in 200 µl of Harju buffer (2% Triton 
X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA). Cells were lysed 




by immersing the tubes in liquid nitrogen for 2 minutes, and then transferred to a 95oC water 
bath for 1 minute. The freeze-thawing was repeated another two more times, following which 
the solution was vortexed for 30 seconds. 200 µl of chloroform was added, and mixed by 
gentle inversion. The mixture was centrifuged at maximum speed in a table-top micro-
centrifuge for 3 minutes. The upper aqueous phase was transferred to a fresh micro-centrifuge 
tube, and 400 µl of ice-cold absolute ethanol was added. After mixing by gentle inversion, the 
mixture was incubated at -20oC for an hour. The precipitated DNA was recovered by 
centrifugation at maximum speed in a table-top micro-centrifuge for 5 minutes. The DNA 
pellet was washed with 70% ethanol, and air-dried. Once dry, the DNA pellet was 
resuspended in 50 µl of sterile deionised water. 
2.3.4 PCR amplification of metacaspase gene YCA1 
The following primers were used to amplify the YCA1 gene from S. cerevisiae 
genomic DNA: 5’YCA1-EcoRI (GCCGAATTCATGTATCCAGGTAGTGGAC) and 
3’YCA1-SalI (GGGCGTCGACTACATAATAAATTGCAGATTTA), with the EcoRI and 
SalI restriction sites underlined respectively. Subsequently, the reverse primer was modified 
to include a hexahistidine tag at the C-terminus of the YCA1 protein: 3'-YCA1-6×His-SalI 
(GCGTCGACTAGTGATGATGGTGATGATGCATAATAAATTGCAGATTTACG). The 
SalI restriction site is underlined, while the nucleotide sequence for the hexahistidine tag are 
in bold. 
PCR was performed using the Expand High Fidelity PCR kit (Roche) using the 
following conditions: initial denaturation was carried out at 95oC for 1 minute; 5 cycles of 
denaturation at 95oC for 1 minute, annealing at 51oC for 1 minute, and elongation at 72oC for 
2 minutes; 25 cycles of denaturation at 95oC for 1 minute, annealing at 51oC for 1 minute, and 
elongation at 72oC for 2 minutes, with the duration for the elongation step increased by 5 
seconds every cycle; elongation at 72oC for 7 minutes; a final hold step at 16oC. 
2.3.5 Molecular cloning 
Molecular cloning was carried out as described in section 2.1.10. 
 




2.3.6 DNA sequencing 
DNA sequencing was carried out as described previously for the PfMCA1 gene 
(section 2.1.11). 




















Table 3. List of sequencing primers used for the various clones of YCA1. As the sequence used is the same for all 
three plasmid vectors, only the first and last sequencing primer was changed. In the case of pESC-HIS, the change 
in name is merely cosmetic. Primers with the same sequence have the same symbol after their names. The 
number at the end represents the position of the primer. 
 
2.3.7 Isolation of yeast total RNA 
Total RNA was isolated from yeast strains according to the protocol of Li et. al 
(2009). Briefly, yeast strains were grown in 3 ml of the appropriate media, and approximately 
2.5 OD600 of yeast culture were harvested by centrifugation. The cell pellet was washed in 400 
µl of DEPC-treated water, before centrifugation at 12,000 rpm for 2 minutes. The cell pellet 
was resuspended in 400 µl of RNA isolation buffer (10 mM EDTA, 50 mM Tris-HCl, 5% 
SDS, pH 6.0). The suspension was incubated in a waterbath at 65oC for 5 minutes, following 
which it was cooled rapidly in ice/water. 200 µl of 0.3 M KCl (pH 6.0) was added to the 
treated cell suspension, and mixed thoroughly to precipitate the SDS. The mixture was 
centrifuged at 12,000 rpm, 4oC for 10 minutes. An equal volume of phenol-chloroform-
isoamyl alcohol (25:24:1) was added to the supernatant, and mixed by inversion, before 
centrifugation at 12,000 rpm, 4oC for 5 minutes. The aqueous layer was recovered and 
precipitation was achieved by addition of 0.1 volume of 3 M sodium acetate (pH 5.2) and 2.5 




volumes of absolute ethanol. The mixture was then incubated at -20oC for 10 minutes. The 
precipitated RNA was pelleted by centrifugation at 13,000 rpm for 10 minutes at 4oC. The 
pellet was washed with 70% ethanol, and centrifuged at 13,000 rpm for 5 minutes at 4oC. The 
pellet was then air-dried before being resuspended in 50 µl of DEPC-treated water. 
2.3.8 Quantification of yeast total RNA 
Yeast total RNA was quantified as described previously for P. falciparum total RNA 
(section 2.1.4). 
2.3.9 Preparation of yeast cDNA 
Yeast total RNA was treated with DnaseI (Promega) according to manufacturer’s 
instructions.  100 ng of the Dnase-treated total RNA was then used for first-strand cDNA 
synthesis using the RevertAidTM H-minus M-MuLV reverse transcriptase from Fermentas 
(according to the manufacturer’s protocol), and oligo-dT primers. The reaction mixture was 
incubated for 60 minutes at 42oC. 4µl of the mixture was then used for PCR. 
2.3.10 Preparation of competent yeast cells 
Transformation was performed according to manufacturer’s (Stratagene) instructions. 
Briefly, an overnight yeast culture was diluted 20× in YPDA medium to a total volume of 50 
ml. The diluted culture was incubated for 4-5 hours before centrifugation at 1,000g for 5 
minutes. The cell pellet was resuspended in 10 ml of LTE buffer (0.1 M LiOAc, 10 mM Tris-
HCl (pH 7.5), 1 mM EDTA) and centrifuged again at 1,000g for 5 minutes. The cell pellet 
was resuspended in 0.5 ml of LTE buffer, and kept at 4oC for up to 3 days. 
2.3.11 Transformation 
3 µl of recombinant plasmid solution (prepared using QIAprep Spin Miniprep Kit) 
and 60 µl of Transformation Mix (40% polyethylene glycol 3350, 0.1 M LiOAc, 10 mM Tris-
HCl (pH 7.5), 1 mM EDTA) was added to 10 µl of the competent yeast cell suspension. The 
mixture was gently inverted several times for homogenisation. The mixture was then 
incubated at 30oC for 30 minutes, after which it was heated at 42oC for 15 minutes. The 
mixture was then centrifuged at 1,000g for 3 minutes, and the pellet resuspended in 100 µl of 
distilled water, before being plated onto histidine-deficient agar plates, and incubated at 30oC. 




2.3.12 Induction of protein expression 
A yeast colony was picked and inoculated in 2 ml of non-inducing selective media 
(containing glucose). The culture was grown overnight in a shaking incubator at 220 rpm and 
30oC. An aliquot of the overnight culture was added to 5 ml of fresh non-inducing selective 
media to OD600=0.05. The diluted culture was incubated in a shaking incubater at 220 rpm, 
30oC to an OD600 of 0.4-0.6. The culture was then centrifuged at 2,000 rpm for 10 minutes, 
and the cell pellet resuspended in an equal volume of the appropriate media (non-inducing, 
containing glucose as a carbon source or inducing, containing galactose). The resuspended 
cultures were then incubated overnight. 
2.3.13 Preparation of yeast protein extracts 
Yeast protein extracts were prepared according to the protocol of Kushnirov (2000). 
Briefly, approximately 2.5 OD600 of yeast cells were harvested from overnight cultures. The 
yeast cells were pelleted by centrifugation at 2,000 rpm for 10 minutes, and the cell pellet was 
resuspended in 100 µl of distilled water, before being transferred to a 1.5 ml tube. 100 µl of 
0.2 M NaOH was added, and the suspension was incubated at room temperature for 5 
minutes. The suspension was centrifuged in a table-top microcentrifuge at 2,000g for 2 
minutes. The cell pellet was resuspended in 50 µl of SDS sample buffer (0.06 M Tris-HCl, 
pH 6.8, 5% glycerol, 2% SDS, 4% β-mercaptoethanol, 0.0025% bromophenol blue), and 
boiled at 100oC for 3 minutes. The boiled suspension was centrifuged at 13,000 rpm for 3 
minutes, and 6 µl of the supernatant was used for SDS-PAGE. 
2.3.14 Purification of hexahistidine-tagged proteins 
1 ml Histrap HP columns (GE Healthcare) were used to purify hexahistidine-tagged 
proteins via immobilized metal ion adsorption chromatography (IMAC), as per 
manufacturer’s instructions. Briefly, proteins extracts were prepared as described above in 
section 2.3.13, except the sample buffer did not contain any bromophenol blue. The sample 
was diluted 100× in binding buffer (20 mM sodium phosphate, 0.5 M NaCl, 30 mM 
imidazole, pH 7.4), and the diluted sample filtered using a 0.22 µm syringe filter. The column 
was washed with 5 column volumes of sterile distilled water, and equlibrated with 5 column 




volumes of binding buffer. The filtered sample was applied to the column, after which 15 
column volumes of binding buffer was used for washing. 5 column volumes of elution buffer 
(20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4), was used to elute the 
bound protein. 
The eluted protein was then concentrated using the Amicon Ultra-4 Centrifugal Filter 
Unit with Ultracel-3 membrane (Millipore), following manufacturer’s instructions. Briefly, 
the eluted fraction was loaded onto the centrifugal unit in 2 ml aliquots, and spun at 3,500g 
for 10 minutes. Once the eluted protein has been concentrated, 100 µl of SDS sample buffer 
was used to recover the retentate, and used for immunoblotting. 
2.3.15 Immunoblotting 
Immunoblotting was performed as described in section 2.2.8. 
2.3.16 Cell viability assays  
Transformed yeast strains were grown overnight in the appropriate medium, and an 
aliquot of the overnight culture was added to fresh medium to an OD600 of 0.05. The freshly 
diluted medium was incubated at 30oC, 220 rpm in a shaking incubator until the OD600 had 
reached 0.4 to 0.6. An aliquot of the cell culture was then transferred to test media used in the 
cell viability assays such that the final cell density was 3×105 cells/ml. Typically, 30 µl is 
added for every 1 ml of the test medium. 
2.3.16.1 Acetic acid assay 
The acetic acid assay was performed as described by Ludovico et al. with 
modifications (Ludovico et al., 2001). Briefly, acetic acid was added to the appropriate yeast 
medium to a final concentration of 80 mM, and pH was adjusted to 3.0 with HCl. Yeast cells 
were introduced into media containing acetic acid at the first timepoint 0 minute. In total, 
there were 5 timepoints – 0, 30, 60, 120, and 200 minutes. At each timepoint, a 1 µl aliquot 
was taken and diluted 1,000×. 100 µl of the diluted sample was plated onto histidine-deficient 
agar plates. The plates were then incubated in a 30oC incubator for 2 days, before the number 
of colony forming units (CFU) was determined by visual counting. 
 




2.3.16.2 Hydrogen peroxide assay 
A modified protocol of Madeo et al., (1999) was used for this assay. Briefly, H2O2 
was added to the appropriate yeast medium to a final concentration of 3 mM. Yeast cells were 
introduced into media containing H2O2 at the first timepoint 0 minute. The timepoints used 
for this assay are the same as that described for the acetic acid assay. Similarly as well, at 
each timepoint, a 1 µl aliquot was taken and diluted 1,000×. 100 µl of the diluted sample was 
plated onto histidine-deficient agar plates. The inoculated plates were then incubated in a 
30oC incubator for 2 days, before the number of colony forming units (CFU) was determined 
by visual counting.  
2.3.16.3 Hyperosmotic shock assay 
Yeast cells were introduced into the appropriate yeast medium containing 60% (w/w) 
glucose at the first timepoint 0 hour. At each timepoints of 0, 1, 2, 4, 6, 8 and 10 hours, 1µl 
aliquots were taken and diluted before being plated onto agar plates, as described previously 
for the acetic acid and H2O2 assays. The inoculated agar plates were incubated at 30oC for 2 
days before determination of CFU. 
 
2.4 Trypanosoma brucei 
2.4.1 Trypanosome strains and culture 
Procyclic T. brucei brucei strain 29.13 cells were used for RNA interference studies 
and stable transfection. They were grown in Cunningham medium with 15% heat-inactivated 
fetal calf serum in the presence of 30 µg/ml phleomycin at 28oC. Procyclic T. brucei 
rhodesiense YTAT cells were used for transient recombinant protein expression. These cells 
were grown in Cunningham medium with 15% heat-inactivated fetal calf serum in the 
presence of 10 µg/ml of blasticidin at 28oC. Fresh media was changed every other day. 
2.4.2 Plasmids 
The p2T7, pLEW100 and pXS2 plasmids were kindly provided by Dr Cynthia He 
(National University of Singapore, Singapore). The p2T7 plasmid was used for RNAi studies 




of the trypanosome metacaspase 4 (TbMCA4). DNA sequences were cloned into the p2T7 
plasmid by bidirectional cloning utilising XbaI restriction sites. 
The pXS2 plasmid utilizes the yellow fluorescent protein (YFP) reporter system – 
YFP will be attached at the C-terminus of the cloned gene. Cloning was achieved by having 
the NheI restriction site and BamHI restriction site at the 5’-end and 3’-end of the sequence 
respectively. 
Transgene expression using the pLEW100 vector is regulated by a tetracycline-
inducible system, and stable integration of the cloned gene was achieved by electroporating 
competent T. brucei cells with linearized fusion pLEW100 plasmids. HindIII and BamHI 
restriction sites were used for cloning of PfMCA1 into the plasmid vector. 
2.4.3 Isolation of T. brucei genomic DNA 
Cells were harvested from a 10 ml culture of T. brucei strain YTAT cells by 
centrifugation at 3,500 rpm for 10 minutes at 4oC. The supernatant was discarded and the cell 
pellet was washed with 1 ml of TE buffer. The cell pellet was resuspended in 0.5 ml of TE 
buffer, and 20 µl of 10% SDS, 10 µl of proteinase K (from a stock of 10 µg/µl solution), and 
10 units of RNase was added. The mixture was homogenised and incubated at 55oC for an 
hour. DNA was extracted and precipitated from the aqueous layer, as described in section 
2.1.2. The DNA pellet was resuspended in 50 µl of sterile deionised water.   
2.4.4 Electroporation 
1×107 T. brucei cells were pelleted at 3000g for 7 minutes and washed in 0.5 volumes 
of cytomix (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4,25 mM HEPES, 2 mM EGTA, 5 
mM MgCl2, pH 7.6). The suspension was centrifuged again, and the pellet was resuspended 
in 1 ml of cytomix. 15 µg of linearized plasmid DNA (stable transfection) or 50 µg of circular 
plasmid DNA (transient transfection) was added to 0.5 ml of the cell suspension in a 0.4 cm 
electroporation cuvette. Electroporation was carried out twice at 1500 V and 25 µF, with a 
10-second pause between the two electroporations. The mixture was then added to 10 ml of 
Cunningham’s media containing 10 µg of phleomycin, and incubated at 27oC. 
 




2.4.5 Molecular cloning 
Molecular cloning was carried out as described in section 2.1.10. 
2.4.6 RNA interference of TbMCA4 
The sequence of TbMCA4 (systematic name Tb10.70.5250) was obtained via 
GeneDB (http://www.genedb.org/), and the fragment to be cloned into the RNAi vector was 
designed by entering the gene sequence into the TrypanoFAN website 
(http://trypanofan.path.cam.ac.uk/software/RNAit.html). The query returned primer 
sequences which amplified a portion of the gene from positions 517 to 1023. These primer 
sequences were modified to include the XbaI restriction sequence for cloning into the p2T7 
plasmid vector. 
The recombinant p2T7 plasmid was linearized using NotI, and the linearized 
plasmied was introduced into T. brucei strain 29.13 via electroporation. After electroporation, 
the cells were kept in Cunningham medium containing 15% heat-inactivated fetal calf serum 
in the presence of 30 µg/ml phleomycin at 28oC. The presence of tetracycline at a 
concentration of 10 µg/ml causes RNA interference of the targeted gene. 
2.4.7 Clonal selection 
T. brucei cells that were successfully transfected were used for clonal selection. 2×106 
cells were diluted 100× in fresh media twice, and 200 µl of the diluted sample was added to 
20 ml of fresh media containing 20 µl of phleomycin and 5000 T. brucei strain YTAT cells. 
200 µl of the mixture was added to each well of a 96-well plate, and the plate sealed with 
paraffin tape. The plate was incubated at 27oC for 2 weeks. Positive clones were identified by 
growth and a change in media colour from red to yellow. 
Four of the positive clones were selected and grown in 10 ml of fresh Cunningham 
media with the presence of phleomycin. These clones were grown for 2-3 days to ensure that 
they were viable. From each clone, 2×107 cells were harvested, and inoculated into 10 ml of 
fresh Cunningham media with phleomycin. A 10 µl aliquot of the culture was taken every 24 




hours, for 4 days, and diluted 10× in PBS buffer. 10 µl of the diluted sample was used for cell 
counting using a Neubauer haemocytometer. 
2.4.8 Isolation of T. brucei total RNA for reverse-transcriptase PCR 
A freshly inoculated culture was incubated overnight, and 2×107 cells from the 
overnight culture were resuspended in 1 ml of fresh medium. Resuspended cultures were 
transferred to a 24-well plate, and tetracycline was added to the culture medium for induction 
of RNAi. 50% ethanol was used as a vehicular control. The plate was incubated at 28oC for 2 
hours, before cells were harvested for total RNA with Trizol (Invitrogen), as per 
manufacturer’s instructions. 
RNA quantification and RT-PCR was carried as described in sections 2.3.8 and 2.3.9 
respectively. 
2.4.9 Concanavalin A treatment 
A freshly inoculated 10 ml culture was incubated overnight, and the cell count 
adjusted to 2×107 cells per ml. 2 ml of the adjusted culture was aliquoted into each well of a 
6-well plate. Concanavalin A (ConA) was added to the desired concentration, and a 10 µl 
aliquot was used for cell counting using a Neubauer haemocytometer every 24 hours, for 96 
hours. 






3.1 Homology of PfMCA1 
YCA1 has been shown to be involved in the attenuation of cell death in S. cerevisiae 
induced by hydrogen peroxide and acetic acid (Ludovico et al., 2001) etc. The protein 
sequence of YCA1 was used in a BLAST search against a P. falciparum 3D7 protein 
database, identifying a putative caspase protein homologue, PF13_0289. PF13_0289 
(PfMCA1) consists of 1,842 bp, and encodes 613 amino acids with a predicted molecular 
weight of 71.7 kDa. A BLAST search using the full-length PfMCA1 protein sequence reveals 
that it has a 42% identity with YCA1. PfMCA1 possesses a universally conserved caspase 
domain from amino acid positions 318 to 551, and the critical histidine and cysteine residues 
which make up the histidine-cysteine dyad of caspases are at positions 404 and 460 of 
PfMCA1 respectively (Fig. 4). 
PfMCA1 is predicted to cleave into two fragments upon processing (Meslin et al., 
2007). Similarly, YCA1 has been shown to be processed in a manner not unlike metazoan 
caspases (Madeo et al., 2002).  It is unknown whether this cleavage event is autocatalytic, or 
it has to be initiated by an unknown protease. Analysis of the N-terminal prodomain revealed 



































Figure 4. In silico studies of PfMCA1. 
A. ClustalW mutilple alignment (using default parameters) of conserved portions of Peptidase_C14/Caspase 
domains of YCA1, PfMCA1, Plasmodium vivax MCA1 (PvMCA1) and Plasmodium berghei MCA1 (PbMCA1). Amino 
acid identity shared by 3 or more of the aligned sequences are shaded. Asterisks denote the critical active site 
histidine and cysteine residues of the catalytic dyad. Sequences are obtained from PlasmoDB 
(http://plasmodb.org/plasmo/home.jsp): PV114725 (PvMCA1), PB001074 (PbMCA1). Adapted from Le Chat L et 
al., 2007. 
B. Predicted struture of PfMCA1. The predicted prodomain contains a putative CARD domain, and the active site 




3.2 Expression of PfMCA1 and YCA1 protein in yeast 
Once the two metacaspases genes had been successfully cloned into the respective 
plasmid vectors, and had been verified by DNA sequencing, the recombinant plasmids were 
used to transform the following yeast host cells, wild-type (WT) and YCA1-knockout 
(∆YCA). Initial attempts to clone the metacaspase genes used PactTHA423 as the plasmid 
vector, and detection of fusion proteins was via the HA tag. 
Attempts to detect the HA-tagged metacaspase proteins via immunoblots did not 
shown any significant bands at the expected positions. The expected size of PfMCA1 is 
B 
A 




approximately 72 kDa and that of YCA1 is approximately 48 kDa. Repeats of the 
experiments using fresh cells showed the same results. 
To eliminate the possibility that the failure to detect the fusion proteins were due to 
the epitope tags, and that the antibodies were not successfully binding to the HA-tag, a 
hexahistidine tag was engineered into the metacaspase gene sequences. This would result in 
six consecutive histidine residues after the metacaspase coding sequence, and this could be 
detected by anti-hexahistidine antibodies. Furthermore, overexpression of a protein can often 
result in the protein being stored in inclusion bodies; fusion tags such as the hexahistidine tag, 
have been shown to enhance the solubility of the fusion protein (Birkholtz et al., 2008; 
Esposito and Chatterjee, 2006), and hopefully allow the detection of the  tagged protein. As 
the hexahistidine tag will bind readily to metal ions, any fusion protein can be purified via 
immobilized metal ion adsorption chromatography (IMAC). However, no tagged proteins 
could be detected from the immunoblots, nor from IMAC-purified fractions, suggesting that 
the proteins themselves were not well-tolerated by the yeast host cells. 
The possibility exists that the expressed metacaspase proteins were toxic to the yeast 
host cells, and were therefore rapidly degraded. The metacaspase proteins were thus 
expressed using an inducible promotor. The metacaspase cloning sequences were cloned into 
the Pgal1-HA-PL-Tactin-423 plasmid vector, and protein expression was induced in the 
presence of galactose. Yeast cells were grown to a predetermined optical density, and the 
carbon source in the medium was changed for protein induction. 
Despite the change from a constitutive to an inducible promotor, no fusion proteins 
could be detected from immunoblots, either using the HA or the hexahistidine tags. 
Surprisingly, no YCA1 fusion proteins could be detected, even though it is a protein 
endogenous to yeast, and previous studies have shown that it is possible to overexpress YCA1 








3.3 Optimization of protein expression 
80.6% of the P. falciparum genome consists of adenosines and thymidines, making it 
one of the most (A+T)-rich genomes ever sequenced to date. The coding sequences of P. 
falciparum genes have an average length of 2.3 kilo base-pairs, larger than other organisms in 
which the gene lengths range from 1.3 to 1.6 kilo base-pairs (Gardner et al., 2002). When 
expressed in E. coli or yeast, the high (A+T)-content of P. falciparum genes could result in 
fortuitous polyadenation or transcription termination signals, leading to undesired truncated 
mRNA transcripts and low levels of mRNA. In addition, the high (A+T)-content translates to 
a codon usage that is dominated by adenosines and thymidines, making it extremely biased 
(Withers-Martinez et al., 1999; Yadava and Ockenhouse, 2003; Zhang et al., 2002). These 
factors combine to make heterologous expression in prokaryotic and eukaryotic systems an 
exceptionally difficult task. However, this situation is not unique to P. falciparum; other 
organisms such as Clostridium tetani (Romanis et al., 1991) and Corynebacterium 
diphtheriae (Woo et al., 2002) also face the same problems. 
In order to circumvent the obstacles that prevent PfMCA1 expression in S. cerevisiae, 
the coding sequence of PfMCA1 was codon-optimized for yeast expression, and any long 
nucleotide sequences containing adenosines and thymidines which might be recognized as 
termination sequences were kept to a minimum. In addition, any glycosylation motifs 
recognized by S. cerevisiae were removed, and the (A+T)-content was increased as much as 
possible to aid protein expression. The optimized coding sequence decreased the (A+T)-
content from 76.35% to 67.32%. While a 9% change may not seem significant by any 
measure, together with the incorporation of a yeast codon bias, it may be sufficient for protein 
expression to be observed.     




   1  ATG                         GAA AAA ATA TAC GTC AAA ATA TAT GAA  30 
   1  ATG CAC CAC CAT CAC CAT CAT GAG AAA ATT TAT GTC AAG ATT TAC GAA  48 
   1  Met His His His His His His Glu Lys Ile Tyr Val Lys Ile Tyr Glu  16 
 
  31  TTG TCT GGA TTA GAA GAT AAG GAT AAT TTT TCA TGT TAT ATA AAA ATA  78  
  49  TTG AGT GGA CTG GAA GAT AAA GAT AAC TTC AGT TGT TAT ATC AAA ATC  96 
  17  Leu Ser Gly Leu Glu Asp Lys Asp Asn Phe Ser Cys Tyr Ile Lys Ile  32 
 
  79  TAT TGG CAG AAT AAG AAA TAT AAA AGT TGT ATA CTT CAA AAG AAT CCA  126    
  97  TAC TGG CAA AAT AAG AAA TAT AAG TCA TGT ATC TTG CAG AAG AAT CCA  144 
  33  Tyr Trp Gln Asn Lys Lys Tyr Lys Ser Cys Ile Leu Gln Lys Asn Pro  48 
 
 127  TAT AAA TTT AAT GAA ATC TTT TTA TTA CCT ATA GAC ATA AAA AAT AAT  174   
 145  TAC AAG TTT AAC GAA ATC TTC TTG CTC CCT ATC GAT ATT AAA AAT AAT  192 
  49  Tyr Lys Phe Asn Glu Ile Phe Leu Leu Pro Ile Asp Ile Lys Asn Asn  64 
 
 175  GTT AAA GAT GAG AAA AAT AAT ATT TTG TCC ATT GAA GTA TGG TCC AGT  222   
 193  GTT AAA GAT GAG AAG AAT AAT ATC CTT TCT ATC GAG GTT TGG TCT TCC  240 
  65  Val Lys Asp Glu Lys Asn Asn Ile Leu Ser Ile Glu Val Trp Ser Ser  80 
 
 223  GGT ATA TTA AAT AAT AAT AAA ATA GCC TAT ACC TTT TTT GAG CTC GAT  270   
 241  GGT ATC TTG AAT AAT AAT AAG ATT GCA TAT ACT TTC TTT GAG TTA GAT  288 
  81  Gly Ile Leu Asn Asn Asn Lys Ile Ala Tyr Thr Phe Phe Glu Leu Asp  96 
 
 271  CAT ATT AGA AGA GAA AGA ATA TCA AGT GAA AAG ATT AAT TTG ATT GAT  318 
 289  CAC ATC AGA AGG GAG CGT ATA TCA AGC GAA AAG ATT AAC CTT ATA GAT  336 
  97  His Ile Arg Arg Glu Arg Ile Ser Ser Glu Lys Ile Asn Leu Ile Asp  112 
 
 319  GTT GTA AAG AAA TGT ACA TTG CAA ATA TCT GTT CAT ATA ATA AAT AAT  366  
 337  GTC GTC AAG AAA TGT ACA CTA CAA ATT AGT GTC CAT ATT ATC AAT AAC  384 
 113  Val Val Lys Lys Cys Thr Leu Gln Ile Ser Val His Ile Ile Asn Asn  128 
 
 367  AAT CAA GAT ATC CTA TTT TGT AAT ATA AAA GAT ATA TTT GGT AAT AAT  414 
 385  AAC CAG GAT ATT CTG TTT TGC AAC ATC AAA GAC ATA TTC GGT AAC AAT  432 
 129  Asn Gln Asp Ile Leu Phe Cys Asn Ile Lys Asp Ile Phe Gly Asn Asn  144 
 
 415  AAA AAT GAT AAA GAA ATA CAT GAT GCC ATA TTA AAA TAT GGA GGT AAT  462  
 433  AAG AAC GAT AAA GAG ATT CAT GAC GCT ATT TTG AAA TAT GGA GGT AAC  480 
 145  Lys Asn Asp Lys Glu Ile His Asp Ala Ile Leu Lys Tyr Gly Gly Asn  160 
 
 463  GAA AGG CAT ATA ATT AAG GAA CTT CGT AAA GAA AAG GAA ATT GGA CAA  510  
 481  GAA AGG CAC ATT ATC AAG GAA TTA AGA AAA GAG AAG GAG ATT GGA CAG  528 
 161  Glu Arg His Ile Ile Lys Glu Leu Arg Lys Glu Lys Glu Ile Gly Gln  176 
 
 511  TAT AAT AAT ATA TAT TTT AAT GAT TAT GTA AAT GTT CTT AAT ACT GAT  558   
 529  TAT AAC AAT ATA TAC TTT AAC GAT TAT GTC AAC GTT CTG AAT ACT GAT  576 
 177  Tyr Asn Asn Ile Tyr Phe Asn Asp Tyr Val Asn Val Leu Asn Thr Asp  192 
 
 559  CCA TCT CAG AAT TAT ATA TAT AAT GAT ATG CCT AAA ATT ACA CCA AAT  606   
 577  CCT TCT CAG AAT TAT ATC TAC AAC GAT ATG CCG AAG ATT ACA CCG AAT  624 
 193  Pro Ser Gln Asn Tyr Ile Tyr Asn Asp Met Pro Lys Ile Thr Pro Asn  208 
 
 
Figure 5. Optimization of the PfMCA1 gene sequence for yeast expression. The original PfMCA1 gene sequence, 
the optimized PfMCA1 gene, and the PfMCA1 amino acid sequence are shown in black, green and blue 
respectively. In the optimized sequence, the nucleotides which have been changed are highlighted in black. In 
addition, a hexhistidine tag has been added after the start codon in the optimized gene sequence. The critical 
histidine and cysteine residues of the catalytic dyad are boxed in grey. 




 607  AAT ATA TAT AAT AAT ATG AAT AAT GAT CAA ACA AAT CAT ACA TAT TTA  654   
 625  AAT ATC TAT AAT AAC ATG AAT AAC GAT CAG ACT AAT CAT ACA TAT CTT  672 
 209  Asn Ile Tyr Asn Asn Met Asn Asn Asp Gln Thr Asn His Thr Tyr Leu  224 
 
 655  AAA GCA CCT AAT AGT TTA TAT AAT AAC GAA AAC ACA ATT TAT TCA TCT  702 
 673  AAA GCA CCA AAT TCA CTA TAC AAT AAT GAA AAT ACT ATC TAC TCT AGT  720 
 225  Lys Ala Pro Asn Ser Leu Tyr Asn Asn Glu Asn Thr Ile Tyr Ser Ser  240 
 
 703  AAT GTA CAT TAT AGC ACT TAT ATG AAC AAT TCA CCT ACT TAT AAA AAT  750   
 721  AAT GTC CAT TAT AGC ACA TAC ATG AAT AAT AGT CCA ACT TAT AAA AAC  768 
 241  Asn Val His Tyr Ser Thr Tyr Met Asn Asn Ser Pro Thr Tyr Lys Asn  256 
 
 751  TCA AAT AAT ATG AAT CAT GTA ACA AAT ATG TAT GCA TCC AAT GAT TTA  798   
 769  AGC AAT AAT ATG AAC CAC GTC ACA AAC ATG TAC GCA TCT AAT GAT TTA  816 
 257  Ser Asn Asn Met Asn His Val Thr Asn Met Tyr Ala Ser Asn Asp Leu  272 
 
 799  CAC AAT TCA AAT CAT TTT AAA CCT CAT AGT AAT GCA TAT AGC ACT ATA  846    
 817  CAT AAC TCC AAT CAT TTC AAA CCT CAC TCT AAC GCA TAT TCG ACT ATT  864 
 273  His Asn Ser Asn His Phe Lys Pro His Ser Asn Ala Tyr Ser Thr Ile  288 
 
 847  AAT TAT GAT AAT AAT AAT TAT ATA TAT CCT CAA AAT CAT ACA AAT ATA  894 
 865  AAC TAC GAT AAC AAT AAT TAT ATA TAT CCT CAA AAT CAT ACC AAC ATT  912 
 289  Asn Tyr Asp Asn Asn Asn Tyr Ile Tyr Pro Gln Asn His Thr Asn Ile  304 
 
 895  TAT AAT AGA GCA TCT CCT GGT AGT GAT CAA ACT TTA TAT TTT TCT CCA  942   
 913  TAC AAT AGG GCT AGT CCG GGA AGT GAT CAA ACT TTA TAC TTC AGT CCA  960 
 305  Tyr Asn Arg Ala Ser Pro Gly Ser Asp Gln Thr Leu Tyr Phe Ser Pro  320 
 
 943  TGT AAT CAA AAG AAA GCA TTG CTT ATT GGG ATA AAT TAT TAT GGA ACC  990 
 961  TGT AAC CAA AAG AAG GCA TTA CTG ATC GGT ATC AAT TAT TAC GGC ACG  1008 
 321  Cys Asn Gln Lys Lys Ala Leu Leu Ile Gly Ile Asn Tyr Tyr Gly Thr  336 
 
 991  AAA TAT GAA TTG AAT GGT TGT ACA AAT GAT ACA CTG AGA ATG AAA GAT  1038 
1009  AAA TAT GAA CTG AAC GGC TGT ACT AAC GAT ACA CTT CGT ATG AAA GAT  1056 
 337  Lys Tyr Glu Leu Asn Gly Cys Thr Asn Asp Thr Leu Arg Met Lys Asp  352 
 
1039  TTG CTA GTA ACA AAA TAT AAA TTT TAT GAT TCC TCA AAT AAT ATA GTT  1086 
1057  TTA TTA GTT ACA AAG TAC AAG TTT TAC GAT TCT TCT AAC AAC ATT GTT  1104 
 353  Leu Leu Val Thr Lys Tyr Lys Phe Tyr Asp Ser Ser Asn Asn Ile Val  368 
 
1087  AGA TTG ATT GAT AAC GAA GCA AAT CCA AAT TAT AGA CCT ACA AGA AGA  1134 
1105  AGA CTA ATT GAC AAT GAA GCA AAC CCG AAT TAT AGA CCC ACA AGA AGA  1152 
 369  Arg Leu Ile Asp Asn Glu Ala Asn Pro Asn Tyr Arg Pro Thr Arg Arg  384 
 
1135  AAT ATT TTA TCA GCA CTT ATG TGG TTA ACT AGG GAT AAT AAA CCA GGA  1182 
1153  AAT ATC TTA AGT GCC TTA ATG TGG TTG ACT AGA GAT AAC AAA CCT GGC  1200 
 385  Asn Ile Leu Ser Ala Leu Met Trp Leu Thr Arg Asp Asn Lys Pro Gly  400 
 
1183  GAT ATT TTA TTT TTC CTT TTT TCA GGA CAT GGA TCA CAA GAA AAA GAT  1230  
1201  GAC ATT CTG TTC TTC CTA TTT TCT GGT CAC GGC TCT CAG GAG AAA GAT  1248 
 401  Asp Ile Leu Phe Phe Leu Phe Ser Gly His Gly Ser Gln Glu Lys Asp  416 
 
1231  CAT AAT CAT ATA GAA AAG GAT GGT TAT AAT GAA TCT ATT CTA CCG TCT  1278 
1249  CAT AAT CAC ATT GAA AAG GAC GGT TAT AAC GAA TCT ATA TTG CCA TCA  1296 
 417  His Asn His Ile Glu Lys Asp Gly Tyr Asn Glu Ser Ile Leu Pro Ser  432 
 
1279  GAT TTT GAA ACA GAA GGT GTA ATT ATT GAT GAT GAA TTA CAT AAA TAT  1326 
1297  GAC TTT GAG ACC GAG GGA GTT ATA ATC GAC GAT GAA TTG CAT AAG TAC  1344 
 433  Asp Phe Glu Thr Glu Gly Val Ile Ile Asp Asp Glu Leu His Lys Tyr  448 





1327  TTA ATT CAA CCC TTA AAT GAG GGA GTA AAA TTA ATA GCT GTT GTA GAT  1374 
1345  CTA ATT CAA CCA CTA AAC GAG GGA GTC AAA TTG ATT GCT GTT GTA GAT  1392 
 449  Leu Ile Gln Pro Leu Asn Glu Gly Val Lys Leu Ile Ala Val Val Asp  464 
 
1375  AGT TGT AAT TCT GGA AGT AGT ATT GAT TTA GCT TAT AAA TAT AAA TTA  1422 
1393  TCG TGT AAT AGC GGT TCT TCT ATA GAC TTG GCT TAT AAG TAC AAG TTA  1440 
 465  Ser Cys Asn Ser Gly Ser Ser Ile Asp Leu Ala Tyr Lys Tyr Lys Leu  480 
 
1423  AAA TCA AAA AAA TGG AAA GAA GAC AAA AAT CCA TTC CAT GTA ATT TGT  1470 
1441  AAA TCC AAA AAG TGG AAG GAA GAT AAG AAC CCT TTT CAC GTG ATT TGT  1488 
 481  Lys Ser Lys Lys Trp Lys Glu Asp Lys Asn Pro Phe His Val Ile Cys  496 
 
1471  GAT GTT ACA CAA TTT AGT GGA TGT AAA GAT AAG GAA GTT TCT TAT GAA  1518 
1489  GAT GTT ACG CAA TTC TCT GGT TGC AAA GAC AAA GAA GTC AGC TAC GAA  1536 
 497  Asp Val Thr Gln Phe Ser Gly Cys Lys Asp Lys Glu Val Ser Tyr Glu  512 
 
1519  GTT AAC ACA GGA CAG ATT GCA CCA GGT GGA TCA TTA GTT ACA GCT ATG  1566 
1537  GTA AAT ACT GGA CAA ATT GCA CCA GGT GGA TCA TTA GTT ACT GCT ATG  1584 
 513  Val Asn Thr Gly Gln Ile Ala Pro Gly Gly Ser Leu Val Thr Ala Met  528 
 
1567  GTA CAA ATT TTG AAA AAT AAT ATG AAT ACA CCT TCT ATT ATA ACT TAT  1614 
1585  GTT CAA ATC TTG AAG AAT AAT ATG AAC ACT CCT TCG ATT ATT ACG TAT  1632 
 529  Val Gln Ile Leu Lys Asn Asn Met Asn Thr Pro Ser Ile Ile Thr Tyr  544 
 
1615  GAA TAC TTA TTA CAT AAT ATA CAT GCT CAT GTC AAA CAA CAT AGT AAT  1662 
1633  GAA TAT TTG CTA CAT AAT ATC CAT GCT CAT GTA AAG CAA CAT AGC AAT  1680 
 545  Glu Tyr Leu Leu His Asn Ile His Ala His Val Lys Gln His Ser Asn  560 
 
1663  CAA ACT GTT ACT TTT ATG TCA TCT CAA AAA TTT AAC ATG AAT AGA CTA  1710  
1681  CAG ACT GTT ACT TTT ATG TCT TCA CAA AAG TTC AAC ATG AAT AGA TTG  1728 
 561  Gln Thr Val Thr Phe Met Ser Ser Gln Lys Phe Asn Met Asn Arg Leu  576 
 
1711  TTC GAT TTT GAA CAT ATA ATT AAG AAC AAA AAT AAC CAA CTA GGG CAA  1758 
1729  TTC GAT TTT GAA CAT ATT ATC AAG AAC AAG AAT AAC CAA CTT GGT CAA  1776 
 577  Phe Asp Phe Glu His Ile Ile Lys Asn Lys Asn Asn Gln Leu Gly Gln  592 
 
1759  ATA ATT AAT AAA TAT ATA GAA AAA AAT AAA AGC AAA AAT AAA AAT AAG  1806  
1777  ATA ATT AAT AAA TAT ATC GAA AAG AAT AAA TCC AAG AAC AAA AAC AAG  1824 
 593  Ile Ile Asn Lys Tyr Ile Glu Lys Asn Lys Ser Lys Asn Lys Asn Lys  608 
 
1807  TTA AAG CAT GAA CTT AAA AAT TTA TTT TTT TTT                      1839                       
1825  CTT AAG CAT GAA TTG AAG AAT TTA TTT TTC TTC                      1857 
 609  Leu Lys His Glu Leu Lys Asn Leu Phe Phe Phe                      619 
                                               
 
 




3.4 Expression of optimized PfMCA1 and YCA1 amplified from mRNA 
The optimized PfMCA1 coding sequence was synthesized by Genscript, and was 
cloned into a commercial vector pESC-HIS (Stratagene). pESC-HIS was chosen as the 
plasmid vector, as it was identical to the one that was used in the initial study that 
overexpressed and characterized YCA1 (Madeo et al., 2002). Proteins expressed using pESC-
HIS would express a FLAG epitope tag at the C-terminus. 
However, the presence of any PfMCA1 could not be detected, using either anti-
histidine or anti-FLAG antibodies (Fig. 6A). This suggested that the failure to express 
PfMCA1 is inherent to the protein itself, and was not due to the expression system. 
To ensure that the yeast expression system was working, the coding sequence of S. 
cerevisiae actin was amplified via PCR from cDNA, using the primers EcoRI-ScActin-fw 
(GCCGAATTCATGGATTCTGAGGTT) and NotI-ScActin-rv (TATAGCGGCCGCGAAA-
CACTTGTGGTG). The EcoRI and NotI restriction sites are underlined respectively. The S. 
cerevisiae actin coding sequence was cloned into pESC-HIS, and protein expression was 
induced. Immunoblotting using yeast transformed with the recombinant plasmid grown under 
inducing conditions (presence of galactose) showed the expected band at 41.7 kDa(Fig. 6B). 
Since there did not seem to be any problems with the expression system, the failure to 
overexpress YCA1, an endogenous yeast protein, seems puzzling. In an attempt to address 
this anomaly, the coding sequence of YCA1 was amplified from S. cerevisiae cDNA. This 
was subsequently cloned into pESC-HIS, and immunoblots showed that the YCA1 gene had 
been successfully cloned and expressed (Fig. 7). This result suggested that a mRNA source 
might be better than a genomic DNA source for gene amplification and subsequent 
expression, despite the fact that both sequences are virtually identical, for all intents and 
purposes. 
When YCA1 was overexpressed in yeast cells, a band of approximately 50 kDa, 
which likely correspond to the predicted size of the full-length protein, was detected. In 
addition, prominent bands averaging 37 kDa in size were also observed for transformed WT 
yeast strains (Fig. 7, lanes 3 & 7), but not in transformed ∆YCA1 yeast strains (Fig. 7, lanes 5 




& 9). This second group of bands most likely corresponds to the catalytic domain of YCA1 
(Madeo et al., 2002; Watanabe and Lam, 2005).  




Figure 6. Overexpression of S. cerevisiae actin. 
Cells were grown in non-inducing media containing glucose (Glu), and in inducing media containing galactose 
(Gal). 
A. Positive and negative controls for immunoblot using anti-FLAG antibodies. FLAG-tagged CD74 (approximately 
37 kDa) was used as the positive control for the antibody. Proteins were harvested from both WT and ∆YCA1 
S.crevisiae, as well as strains transfomed with the empty pESC-HIS vector. Protein loading was determined by 
Coomassie Blue staining (shown below the immunoblot). Precision Plus Protein Dual Color standard (Bio-Rad) 
was used as the protein marker. 
B. Detection of FLAG-tagged S. cerevisiae actin. The coding sequence for actin was cloned into pESC-HIS, and the 
recombinant plasmid (pESC-ScActin) was used to transform WT and ∆YCA1 S. cerevisiae. The FLAG-tagged actin 
was predicted to have a size of 41.7 kDa. Protein extracts were harvested and separated on an SDS-PAGE gel. 
Protein loading was determined by Coomassie Blue staining (shown below the immunoblot). Two clones were 
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Figure 7. Overexpression of YCA1. Both WT and ∆YCA yeast were transformed with pESC-HIS containing the 
YCA1 coding sequence. Transformed yeast were grown in both non-inducing (Glu) and inducing media (Gal). 
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3.5 PfMCA1 mRNA levels in transformed yeast 
 To further understand why PfMCA1 could not be expressed in S. cerevisiae, RNA 
was isolated from both WT and ∆YCA1 yeast transformed with the full-length PfMCA 
coding sequence. Using oligo-dT primers, the mRNA fraction of the total RNA pool was 
converted into cDNA. The cDNA was used for PCR amplification using S. cerevisiae actin-
specific and PfMCA1-specific primers (Fig. 8). Actin-specific primers were used as a control 
for the RT-PCR reaction, while PfMCA1-specific primers were used to detect any PfMCA1 
transcripts. 
 
                        WT (Glu)        WT (Gal)        ∆YCA (Glu)      ∆YCA (Gal)_  
         M    Ac     P      Ac     P      Ac      P      Ac     P 
A 
B                        WT + pESC-PfMCA1                        ∆YCA + pESC-PfMCA1       _ 
                   Clone 1                 Clone 2               Clone 1                 Clone 2      _ 
               Glu          Gal        Glu         Gal         Glu        Gal         Glu         Gal  _ 









Figure 8. Reverse-transcriptase PCR of RNA isolated from WT & ∆YCA1 yeast transformed with PfMCA1. 
S. cerevisiae actin-specific primers would give a 117 bp band, while the PfMCA1-specific primers would give a 310 
bp band. A 2.5% (w/v) agarose gel was used for electrophoresis. 
A. Gel shows the controls for the primers used for RT-PCR. Actin-specific primers (Ac) and PfMCA1-specific primers 
(P) were used to detect actin and PfMCA1 mRNA transcripts respectively. RNA was obtained from WT and ∆YCA 
yeast grown in both non-inducing (Glu) and inducing media (Gal). Actin mRNA is present in all samples, while no 
PfMCA1 mRNA was observed. Lane M: DNA ladder 
B. RT-PCR was performed on several clones of PfMCA1-transformed yeast. The same actin-specific (Ac) and 
PfMCA1-specific (P) primers were used for detecting the presence of the respective mRNA transcripts in both WT 
and ∆YCA yeast transformed with the pESC-PfMCA1 plasmid, grown in both non-inducing (Glu) and inducing 
media (Gal). Lane M: DNA ladder. 




RT-PCR performed on cDNA samples obtained from untransformed WT and ∆YCA1 
yeast showed the expected band for actin, and the absence of any bands using PfMCA1-
specific primers (Fig. 8A). No PfMCA1 mRNA transcripts were present in the yeast host 
strains, and any that were detected had to be due to the presence of the PfMCA1-pESC 
recombinant plasmid. 
Indeed, cDNA obtained from PfMCA1-transformed WT and ∆YCA1 yeast cells 
showed positive bands when PfMCA1-specific primers were used. Interestingly, the PfMCA1 
mRNA transcripts could be detected even in samples that were grown in non-inducing 
conditions (Fig. 8B).  
Despite the presence of PfMCA1 transcripts in transformed yeast cells grown under 
inducing conditions, no protein products could be detected. This observation suggests that the 
protein has an extremely high rate of turnover, and it is rapidly degraded, perhaps as soon as it 
is made. Alternatively, the mRNA may be regulated in a manner such that even though 
transcripts were present, these transcripts were not further processed for translation.  
 
3.6 Low complexity regions in PfMCA1 
SEG analysis showed that 43%, almost half of the protein consists of low complexity 
regions. Low complexity regions are believed to form non-globular protein domans, and the 
strong presence of low complexity regions is not uncommon, although it is unique to P. 
falciparum proteins (Pizzi and Frontali, 2001). Low complexity regions exceeding 29% of the 
total protein primary structure often prevents successful heterologous expression (Birkholtz et 
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Table 4. SEG output showing low complexity regions in PfMCA1. 
Close to 50% of the PfMCA1 protein consists of regions of low complexity. 
  




3.7 Expression of optimized PfMCA1 in E. coli 
To see whether PfMCA1 could also be expressed using other protein expression 
systems, the optimized PfMCA1 coding sequence was cloned into an E. coli expression 
vector, pGEX. The pGEX vector allows for high level of inducible protein expression in E. 
coli as fusion proteins with the glutathione S-transferase (GST) enzyme at the C-terminus. 
The empty vector and the recombinant vector with PfMCA1 (PfMCA-pGEX) were used for 
transformation of E. coli strain BL21 (DE3). 
Using anti-histidine antibodies, immunoblots using protein extracts from transformed 
E. coli cells did not show any positive bands (Fig. 9A). On the other hand, anti-GST 
antibodies revealed a whole range of positive protein bands (Fig. 9B). This was attributed to 
heavy background contamination, as bands were observed even in samples obtained under 
non-inducing conditions. The Coomassie Blue stain (Fig 9A) showed the expected GST 
protein at the 25 kDa band with samples transformed with the empty pGEX vector and grown 
under inducing conditions. However, no significant band was observed at the 100 kDa mark, 
which is the approximate combined size of PfMCA1 and the GST moiety. 




Figure 9. Immunoblot of protein isolated from E. coli BL21 
A. Immunoblot using anti-histidine antibodies. E. coli BL21 were 
transformed with both the empty vector (pGEX) and a 
recombinant vector containing the PfMCA1 coding sequence 
(pGEX-PfMCA1). No positive bands were observed under both 
non-inducing (IPTG(-)) and inducing conditions (IPTG(+)). The 
Coomassie Blue-stained gel shown was used to control for 
protein loading. It can be seen that the GST protein 
(approximately 27 kDa) was produced under inducing 
conditions. 
B. Immunoblot using anti-GST antibodies. Samples loaded were 
exactly the same as A, but the membrane was probed with 
anti-GST antibodies instead. High levels of background were 
observed, and it is inconclusive as to whether any fusion 
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3.8 Expression of optimized PfMCA1 in T. brucei 
Attempts were made to express PfMCA1 in trypanosomes using T. brucei as the host. 
The expressed PfMCA1 protein would be tagged with yellow fluorescent protein (YFP), 
allowing visual confirmation of protein expression with a fluorescence microscope. Not 
unlike Plasmodium, trypanosomes are unicellular bloodborne parasitic protozoa, and they 
possess five metacaspases, one of which has been implicated in S. cerevisiae cell death 
(Szallies et al., 2002). 
Transient expression of PfMCA1 had a small degree of success. The optimized 
sequence of PfMCA1 was used throughout these series of experiments on T. brucei. Yellow 
flourescent trypanosomes were observed in both healthy and dying cells (loss of characteristic 
cell morphology) (Fig. 10). The percentage of cells that successfully express PfMCA-YFP 
was also low – out of the 1×107 trypanosome cells that were electroporated, only an average 
of 10 cells were observed to be glowing yellow. A much larger area also had to be visually 
scanned before a fluorescent trypanosome could be located. In contrast, fluorescent 
trypanosomes could be immediately observed when they were transformed with the empty 
plasmid vector. Often, within the same field, several fluorescent trypanosomes could be seen, 
while only a single fluorescent trypanosome could be seen for those expressing PfMCA1. 
These observations suggest that the PfMCA1 protein has an extremely low level of expression 
in trypanosomes, and it may somehow be involved in trypanosomal cell death. 
In an attempt to increase the expression level of PfMCA1 in trypanosomes, the 
PfMCA1 gene was stably-integrated into the genome of T. brucei. While cultures of 
transformed T. brucei could be grown in the presence of antibiotics, no viable clones could be 
isolated. An interesting observation is that under inducing conditions, growth of the 
transformed trypanosome culture was slower than that of a similar culture growing under non-
inducing conditions, suggesting that even though there was no detectable expression of 
PfMCA, its expression has a negative impact on cell growth.  
  
Figure 10. Expression of PfMCA1-YFP fusion proteins in T. brucei. PfMCA was cloned into a T. brucei expression plasmid vector, and transiently expressed. 
Trypanosomes transformed with an empty vector showed the expected yellow fluorescence. PfMCA1 could be expressed in trypanosomes, as evidenced by the same 
yellow fluorescence when the vector with the PfMCA1 gene was used for transformation. However, the degree of expression is significantly lower than that of the 
empty vector. In addition, expression of PfMCA1 could be found in healthy cells (middle row), as well as cells that are dying (bottom row). Dying cells tend to lose the 
characteristic shape of the trypansomes and exhibit a round morphology. Photos were taken with live, moving cells, hence in the composite images, the images may 









































































































































































































































3.9 RNAi in T. brucei 
A nucleotide sequence was designed to silence metacaspase 4 of T. brucei 
(TbMCA4), as a previous study has shown that it is involved in the cell death pathway of S. 
cerevisiae (Szallies et al., 2002). This was cloned into the p2T7 vector, and the recombinant 
plasmid was inserted into T. brucei cells via electroporation. 
Successful clones were isolated, as described in section 2.4.7, and four clones were 
picked for reverse-transcriptase PCR, to ensure that the RNAi was successful (Fig. 11). The 
silencing effect is inducible, and is controlled by a Tet system. Presence of tetracycline in the 
culture medium would induce the production of the interfering RNA, leading to gene 
silencing.  
 
Of the four clones that were isolated, only one showed a presence of TbMCA4 
mRNA transcripts (819 base-pairs) before RNAi induction, and demonstrated a significant 
decrease after (Fig. 11, lanes 5 & 6). The other three clones did not show any significant 
levels of TbMCA4 mRNA under both conditions, even though the level of actin transcripts 
(390 base-pairs) remained constant throughout for the four clones (Fig. 11, lanes 7 & 8). 
Figure 11. Reverse-transcriptase PCR of RNA extracted from T. brucei clones. 
RNA was extracted from isolated T. brucei clones that had been successfully transformed with a TbMCA4 RNAi 
fragment. Isolated clones were grown under RNAi-non-inducing (Tet-) and inducing conditions (Tet+). Lanes 1 -4  
used actin-specific primers for PCR, and lanes 5-8 used TbMCA4-specific primers. Lanes 1, 2, 5 and 6 represent 
RNA isolated from the same clone, while lanes 3, 4, 7 and 8 represents a second clone. In total, 4 clones were 
isolated, but the remaining clones showed the same results as the second clone. Lane M are loaded with DNA 
ladder. Both lanes are identical. 
                           Actin                                      TbMCA4             a 
                Tet-    Tet+    Tet-    Tet+                Tet-    Tet+     Tet-    Tet+   









3.10 Concanavalin A treatment assay 
The TbMCA4-silenced clone previously isolated was used to determine the effect of 
TbMCA4-knockdown via treatment with ConA. Initial results using 50 µg/ml of ConA 
showed a lethal rate of almost 100%. No viable trypanosomes were observed, and those that 
did survive displayed sluggish movement. For practical purposes, it was decided the 
determination of the ideal concentration of ConA would begin with smaller concentrations.  
Preliminary results showed that at 1.0 µg/ml of ConA, there were very little 
differences between the various conditions (Fig. 12A). Owing to significant variation in the 
results, it would be difficult to draw any significant conclusions. 
A cleaner picture was obtained using 2.5 µg/ml of ConA (Fig. 12B). For ConA-
treated cultures, TbMCA4-silencing (Fig. 12B, Tet+ ConA+) led to a greater survival rate, 
compared to the non-TbMCA4-silenced cultures (Fig. 12B, Tet- ConA+). The silenced 
cultures also experience a much more gradual increase and decrease in cell density (Fig. 12B, 
Tet+). TbMCA4-silencing probably comes with a metabolic cost, resulting in a much slower 
growth rate, but such cells demonstrate a greater resistance to cell death caused by nutrient 
depletion and senescence. In contrast, cultures still expressing TbMCA4 showed a steeper 
increase after 48 hours, possibly due to depletion of ConA in the culture medium (Fig. 12B, 
Tet-). This decrease in ConA concentration would allow any survivors to rapidly divide, since 
the selection pressure has dropped. Once the nutrients in the medium had been used up, the 
cells die at a faster rate as they are less resistant to cell death. 
In cultures treated with PBS, the vehicular control for ConA, TbMCA4-silenced cells 
also show a much slower growth rate, but have a greater resistance to cell death due to 
senescence (Fig.12B, Tet+ ConA-). In contrast, the non-silenced cultures grow and die more 
rapidly, suggesting that TbMCA4 might be involved in cell homeostasis. (Fig.12B, Tet- 
ConA-) 













































































 Figure 12. Effect of concanavalin A on TbMCA4-knockdown T. brucei cells. 
T. brucei cells were treated with or without tetracycline, and with or without ConA. The assay was performed 
using 1.0 µg/ml (A) and 2.5 µg/ml ConA (B). Cells were counted visually every 24 hours for 96 hours. The assay 
was performed in triplicate, and an average of the three samples was used to obtain the value at each timepoint. 
Each timepoint using 1.0 µg/ml ConA represents an average of two readings. The third reading could not be used 
as the samples were not viable due to an unknown cause. Error bars represent the standard error. Raw data and 
calculations can be found in the appendix. 
For the same time-point, pairs of data were compared, e.g. Tet-ConA- and Tet-ConA+, using the unpaired, two-
tailed student’s t-test, assuming unequal variance. For the values obtained using 1.0 µg/ml of ConA, the presence 
of ConA were not statistically significant (p-value>0.05). However, increasing the ConA to 2.5 µg/ml significantly 
decreased the viability of the cells (p-value<0.05). Calculations can be found in the appendix. 
A 
B 




3.11 Site-directed mutagenesis of PfMCA1 
 The critical cysteine and histidine residues of the catalytic dyad have been identified, 
and to find out if these residues were important for enzymatic activity as predicted, they were 
mutated to alanine residues. The enzymatic activity of PfMCA1 may have an effect on the 
ability to express PfMCA1 heterologously, as the activity of PfMCA1 could be detrimental to 
the cell expressing it, resulting in low expression levels. 
The full length optimized PfMCA1 gene sequence containing the cysteine-to-alanine 
mutation was cloned in the yeast plasmid vector pESC, and the DNA sequence was verified 
by DNA sequencing. Subsequent expression of the mutated protein in WT or ∆YCA1 yeast 
was not successful, despite repeated attempts. 
 
3.12 Expression of PfMCA1 protein domains 
 Protein structural data on PfMCA1 retrieved from PlasmoDB 
(http://plasmodb.org/plasmo/home.jsp; Gene ID PF13_0289) identified amino acids 318 to 
551 (amino acids 324 to 557 in the optimized coding sequence) as a conserved C14-peptidase 
caspase domain. BLASTing the protein sequence of PfMCA1 against a database of conserved 
protein domains showed the same result. 
A set of PCR primers were designed to express the PfMCA1 protein from amino 
acids 1 to 317 (non-catalytic domain), and another set to express the rest of the PfMCA1 
protein from amino acids 318 (catalytic domain) onwards. The optimized coding sequence of 
PfMCA1 was used, and the hexahistidine tag at the N-terminus was removed from the 
sequence. These two fragments were cloned into the pESC yeast plasmid vector, and 
expressed in both WT and ∆YCA1 yeast cells. 
The results of the expresson of the catalytic domain were similar to the expression of 
the full-length protein. No expression could be detected with immunoblotting, even with 
repeated attempts. 




In contrast, expression of the non-catalytic domain could be observed. A predicted 
protein band approximately 35 kDa in size was could be detected on the immunoblot (Fig. 
13). While expression of the non-catalytic domain was strong in the WT yeast cells, with a 
thick band being observed, expression in ∆YCA1 yeast cells was relatively weak.  
 
Figure 13. Expression of the protein domains of PfMCA1. The catalytic domain of PfMCA1 (amino acids 318 to 
613) could not be expressed (results not shown). On the other hand, the expression of the non-catalytic domain 
of PfMCA1 (amino acids 1 to 317) could be successfully detected. A protein band corresponding to the predicted 
size (35 kDa) of the non-catalytic domain could be seen in both transformed WT and ∆YCA1 yeast cells. It is 
interesting to note that the expression levels of the non-catalytic domain varied between the two yeast strains. 
The expression was strong in transformed WT yeasts, but it was extremely weak in transformed ∆YCA1 yeasts, 
almost undetectable. Two clones were isolated and tested for protein expression. The Coomassie Blue stain 
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Previously, programmed cell death has been extensively studied only in multicellular 
systems, as it was first observed in metazoans, and it seemed only natural to assume that any 
organism that would benefit from such a cell suicide program would be a multicellular one. 
Afterall, it made no altruistic sense for unicellular organisms. 
However, in the last decade or so, it was discovered that PCD is not exclusive to 
metazoans, but that it is present as well in unicellular eukaryotes. This has sparked great 
interest in the subject, and several studies have been conducted to study this phenomenon and 
its similarities to classical PCD, including its mediators and pathways. 
Many studies have found characteristics of PCD in Plasmodium, induced by a variety 
of agents, such as febrile temperatures (Oakley et al., 2007), reactive oxygen species (Kumar 
et al., 2007), platelets (McMorran et al., 2009) and drugs (Meslin et al., 2007). However, this 
has been disputed by other studies. Al-Olayan et al., (2002) have shown that hallmarks of 
PCD, such as chromatin condensation and phosphatidylserine exposure, were present in 
malarial parasites that were invading the mosquito midgut. However, these results could not 
be replicated when attempted by Le Chat et al., (2007). Other studies also failed to detect 
signs of PCD in malaria parasites (Deponte and Becker, 2004; Nyakeriga et al., 2006; Totino 
et al., 2008). 
Regardless, a class of caspase-like proteins, the metacaspases, have the potential to 
act as mediators in the PCD pathway, and this was first demonstrated by Madeo et al., (2002), 
when they showed that a knockout of the S. cerevisiae metacaspase YCA1 was more resistant 
to cell death-inducing stimuli. It was also fortuitous that this was done in yeast, as it gave 
other researchers a model eukaryotic system to investigate metacaspases from other 
organisms. 
Of the three metacaspases that have been identified in P. falciparum, PfMCA1 bears 
the greatest similarity to YCA1, and it has been postulated to possess a similar function. To 




date, only one study has attempted to study the characteristics of PfMCA1 (Meslin et al., 
2007). However, that particular study has only managed to demonstrate the successful 
heterologous expression of PfMCA1; it still remains to be seen if it is functionally similar to 
YCA1, or has other biological functions. 
There were several obstacles during the course of this study. For example, PfMCA1 
required several rounds of optimization before it could be successfully amplified, and coupled 
with operator unfamiliarity with the techniques involved, an inordinate amount of time was 
spent cloning the PfMCA coding sequence into yeast expression vectors. 
 
4.1 Molecular cloning 
Initially, genomic DNA was isolated from a culture of P. falciparum strain 3D7 using 
the QIAamp DNA Blood Mini Kit (QIAgen). The kit utilises a silica-gel membrane to 
selectively bind DNA while allowing other cellular debris and contaminants to be washed 
away. Pure DNA is then released from the membrane when it is incubated with either water 
or the elution buffer provided with the kit. 
During normal development, Plasmodium parasites break down proteins in 
erythrocytes to obtain amino acids to support their growth. As haemoglobin makes up a 
significant proportion of the total protein content of erythrocytes, Plasmodium parasites have 
to find a way to detoxify the toxic haem residues that are produced during haemoglobin 
degradation. This is achieved by converting the haem residues to haemozoin crystals 
(Kirchgatter and Del Portillo, 2005). 
This poses a unique problem with the isolation of genomic DNA using the QIAamp 
kit. A significant amount of the haemozoin pigment was retained on the silica-gel membrane, 
leading to poor yield of DNA after elution, possibly due to occlusion of the silica-gel 
membrane, which resulted in a lower available surface area for DNA binding. The first 
extraction only yielded 2.6 ng/µl of DNA; subsequent repeats of the isolation protocol only 
slightly improved the yield to approximately 15 ng/µl. Using higher quantities of parasites did 




not improve the yield significantly, suggesting that the rate-limiting factor was the adsorption 
of genomic DNA to the silica-gel membrane. Despite the low yield, the quality of the isolated 
genomic DNA was within acceptable parameters – spectrometry readings using the 
NanoDrop machine showed the DNA to be free of any contaminating proteins or 
carbohydrates. 
The genomic DNA was used for amplifying the Plasmodium metacaspase gene, 
PfMCA1, which is 1,842 base-pairs in length, using the primers 5’PfMCA-EcoRI and 
3’PfMCA-SalI. In an attempt to determine the optimum annealing temperature, gradient PCR 
was performed, ranging from 30-60oC. Several attempts were made to optimize the annealing 
temperature, but only faint bands were observed throughout the entire range of annealing 
temperatures. While these faint bands were of the expected size, there was significant 
smearing and unspecific products due to primer-dimer formation. 
In order to obtain genomic DNA of higher quality for PCR amplification, the phenol-
chloroform method was used instead. Due to the organic nature of the reagents, DNA is 
cleanly partitioned in the aqueous phase, allowing a much greater yield of genomic DNA, as 
compared to using a kit. Indeed, significantly higher amounts of DNA (approximately four 
times more) were obtained with the same amount of parasites, with typical yields ranging 
from 30 to 60 ng/µl. 
Using this genomic DNA as a template, PCR conditions were optimized by varying 
the conditions one at a time. Previous gradient PCR runs indicated that the optimum 
annealing temperature for the PfMCA1 gene lies between 40oC and 60oC. Further 
investigation revealed the PCR yield reached a peak at a temperature of 51oC. However, this 
wasn’t sufficient for subsequent molecular cloning, as the band was still deemed too faint. 
Adjusting the Mg2+ concentration to 2.0 mM in the PCR reaction mix improved the intensity 
of the band significantly. 
Compared to PfMCA1, amplification of the YCA1 gene was relatively 
straightforward. Genomic DNA isolated using the protocol of Harju et al., (2004) was used 
for PCR amplification using the primers 5’YCA1-EcoRI and 3’YCA1-SalI. Sufficient 




amounts of YCA1 PCR products were obtained with a Mg2+ concentration of 1.5 mM and an 
annealing temperature of 51oC, hence no further optimization was carried out. 
The PfMCA1 and YCA1 PCR products were digested with the restriction enzymes 
EcoRI and SalI. The plasmid vector PactTHA423 was similarly digested. The digested 
products were then ligated together in various ratios, using the following formula 
 
where kbp refers to kilo base-pairs. However, initial attempts to transform E. coli strain DH5α 
cells proves unsuccessful. Very few, or no positive colonies were observed when the 
transformed cells were plated onto LB agar plates in the presence of ampicillin. Restriction 
enzyme analysis of the plasmids extracted from the positive clones did not reveal any 
successful clones. 
Further investigation revealed that a high proportion of the digested plasmid vector 
underwent self-recircularization, resulting in an extremely low cloning efficiency. This was 
entirely unexpected as the plasmid vector was digested with two different restriction 
endonucleases to give incompatible ends, and as such, would prevent such self-
recircularization from ever occuring in the first place. To prevent such recircularization and 
improve the cloning success rate, the plasmid vector was treated with Antarctic Phosphatase 
(New England Biolabs) to remove the phosphate group. The phosphate group is an important 
element of the ligation process, and its absence from the plasmid vector meant that any 
ligation reaction would require the phosphate group from an exogenous source. In this case, 
the phosphate group would come from the gene sequence to be inserted into the plasmid 
vector. The cloning efficiency improved significantly after treatment of the plasmid vector 
with phosphatase, and subsequent cloning efforts incorporated the phosphatase treatment. 
Expression of PfMCA1 in yeast cells was unsuccessful, despite extensive 
troubleshooting. Initial DNA sequencing revealed several mutations in the coding sequence, 
which could have resulted in premature termination or nonsense codons. Taq polymerase has 




a relatively low fidelity, having an error rate of 1 in 9,000, and a frameshift mutation rate of 1 
in 41,000 (Tindall and Kunkel, 1998). Taq polymerase also does not possess any 3’→5’ 
exonuclease proofreading capabilities (Lawyer et al., 1993), making it unable to correct any 
mistakes it has made during the replication process. 
PfMCA1 is a long gene, 1,842 base-pairs in length, and the error rate of Taq 
polymerase means that approximately 1 in 5 copies will possess an error of some kind. If the 
mutations occur early in the PCR process, the amount of error-free products will be extremely 
small, due to the exponential amplification power of PCR. This prompted the change of DNA 
polymerase from Taq to a high fidelity polymerase system, significantly reducing the amount 
of mutations in the coding sequence. The new PCR system utilizes a polymerase mixture 
comprising of Taq and Tgo polymerases. The Tgo polymerase compensates for the lack of 
proofreading capability in Taq, increasing the fidelity of DNA replication by a factor of 3, and 
dramatically increasing the amount of error-free PCR products. 
Interestingly, the amount of mutations/errors observed with YCA1 is much less than 
that observed for PfMCA1. Often, with Taq polymerase, PfMCA1 recombinant plasmids sent 
for sequencing results in all of them having an error of some kind, while YCA1 recombinant 
plasmids have few or almost no mutations at all. This may be in part due to YCA1 being of a 
smaller size (1,296 base-pairs), but it seems that the high (A+T)-content of PfMCA1 gene 
plays a more significant role. A-T base-pairs consists of two hydrogen bonds, and with a high 
(A+T)-content, much lower annealing temperatures are required, leading to non-specific 
priming and misannealing of primers (Chevet et al., 1995). Continuous stretches of 
adenosines and thymidines in the coding sequence could also also have led to copy errors in 
the PCR products (Mehlin et al., 2006). 
 
4.2 PfMCA1 expression in S. cerevisiae 
Plasmodial proteins are notoriously difficult to express heterologously in host 
expression systems, and a variety of teachniques have to be employed for successful 




expression (Birkholtz et al., 2008). While there have been successful cases of expressions 
(Meslin et al., 2007; Salas et al., 1995; Withers-Martinez et al., 1999; Yadava and 
Ockenhouse, 2003; Zhang et al., 2002), difficulties with expression have hindered detailed 
biochemical and functional analyses (Birkholtz et al., 2008; Salas et al., 1995)s. Early 
attempts at PfMCA1 expression in yeast did not yield positive results, and this remained so 
with both constitutive and inducible promotors. 
Several reasons have been postulated to account for the difficulties that were 
encountered in attempting to express plasmodial proteins. As mentioned earlier, the high 
(A+T)-content of the plasmodial genomes, as high as 80% for P. falciparum, have been 
blamed for the low level of expression. Long repeats of adenosine and thymidine bases make 
it difficult for host organisms to replicate and translate faithfully. However, studies  have 
shown that the (A+T)-content is not a significant factor in protein expression, at least in E. 
coli (Mehlin et al., 2006; Vedadi et al., 2007). 
Instead, the high (A+T)-content translates to a codon bias that greatly hinders protein 
expression. (A+T)-biased codons, such as lysine and asparagine, means that these amino acids 
are used up relatively quickly (Vedadi et al., 2007), and the prevalance of rare codons, e.g. 
AGA and AGG in E. coli, imposes a metabolic strain on the host (Birkholtz et al., 2008). This 
can trigger a phenomenon known as ribosomal stalling, where the lack of certain amino acids 
causes peptide elongation to stop and terminate (Birkholtz et al., 2008), leading to truncated 
proteins and low expression levels. 
Another reason put forward for the low expression of plasmodial proteins suggests 
that plasmodial proteins are toxic to the host organism. This results in a lower growth rate of 
the host cells, and the complete lack of protein expression (Birkholtz et al., 2008; Cinquin et 
al., 2001; Mehlin et al., 2006). It is not hard to imagine that the cell would prevent the 
synthesis of proteins that it deems toxic to itself. 
In order to successfully express PfMCA1 in yeast, two important problems had to be 
overcome, that of tRNA exhaustion, and preventing long stretches of adenosines from being 
recognized as polyadenation or transcription termination signals. The protein sequence of 




PfMCA1 was reverse-translated into a DNA sequence which will suit the codon bias of the 
host organism, in this case, S. cerevisiae. Synthetic genes can be manufactured by a 
sequential series of PCR, generating desired fragments via careful design of primers and 
subsequent assembly of the entire coding sequence using these fragements. This approach has 
allowed the successful expression of the P. falciparum subtilisin-like protease pfsub1 in 
Pichia pastoris, an alternative yeast expression system (Withers-Martinez, 1999). 
A caveat to this expression strategy is that successful expression is not always 
guaranteed. Not all synthetic genes could be expressed, and even for those that were, some 
ended up being sequestered in inclusion bodies (Mehlin et al., 2006). A study that used E. coli 
as an expression system revealed that codon bias was not a significant factor in the expression 
level of individual genes. Instead, the stability and free energy of the mRNA, i.e its secondary 
structure, plays a more critical role (Kudla et al., 2009). 
Even within the yeast cell, there are several things that could go wrong. Protein 
production can be too efficient, leading to a high concentration of proteins in the endoplasmic 
reticulum. This can signal the yeast to start the degradation of such aggregated proteins via 
the ubiquitination pathway (Mattanovich et al., 2004). Yeast proteins that are responsible for 
ensuring correct folding and disuphide bond formation could also differ from those in P. 
falciparum, resulting in an aberrant form (Romanos et al., 1992). 
While there are many considerations that had to be taken into account, the decision 
was taken to synthesize a codon-optimized PfMCA1 coding sequence suitable for expression 
in S. cerevisiae. It would have been impossible to predict with absolute certainty whether 
such a synthetic gene could be successfully expressed – the only way to know for sure would 
be to actually clone the gene and test for expression. 
Disappointingly, no expression could be detected with the synthetic gene. The central 
dogma of molecular biology states that in order to obtain protein from DNA, DNA has to be 
first transcribed to RNA, followed by a translation from RNA to protein (Crick, 1970). The 
RNA of various yeast transformants was isolated, and using PfMCA1-specific primers (and 
actin-specific primers as controls) for RT-PCR, it was discovered that PfMCA1 transcripts 




were present. While this would not be surprising in yeast transformants grown under inducing 
conditions, PfMCA1 mRNA transcripts were also present under non-inducing conditions, 
suggesting that at the very least, there was basal transcription of the gene present. This could 
be possibly caused by the leaky transcription of the HIS3 auxotrophic selection gene (Pratt et 
al., 2007; Tian et al., 2001) and GAL10 promotor (Ruhela et al., 2004), resulting in a 
background level of PfMCA1 transcripts. 
Evidence suggests that the yeast host cells do not tolerate the presence of the 
PfMCA1 protein very well, resulting in a lack of expression. Since expression in yeast has 
proven fruitless, other alternative expression systems were considered. 
 
4.3 PfMCA1 expression in E. coli 
E. coli is a commonly used host expression system, as the bacteria itself grows 
relatively quickly, and it is cheap, easy to use and genetically manipulate. The synthetic 
version of PfMCA1 was cloned into a pGEX vector, and the recombinant plasmid was used 
for transformation of E. coli strain BL21 (DE3). This strain of E. coli was chosen as the 
bacterial host for expression as it is protease-deficient, allowing for a greater degree of protein 
stability (Studier et al., 1990). To minimize the amount of protein being sequestered in 
inclusion bodies, bacterial cultures were incubated at room temperature. This would reduce 
the rate of protein synthesis, and would hopefully allow soluble expression. 
The recombinant PfMCA1 protein would be expressed with a hexahistidine tag at the 
N-terminus, and a GST-moiety tag at the C-terminus. Unfortunately, no expression could be 
detected with anti-histidine antibodies. Using anti-GST antibodies resulted in an immunoblot 
with high levels of background, making it impossible to reach any significant conclusions. 
The Coomassie Blue stain stained gel, however, showed clearly that no PfMCA1 protein had 
been expressed. In bacteria that was transformed with the empty pGEX vector, those were 
grown under inducing conditions had an obvious band approximately 25 kDa in size, as 
opposed to none in bacteria without induction. This band corresponds to the size of the GST 




moiety (27 kDa), which would be the only protein that would be heterologously expressed 
with an empty pGEX vector. 
In contrast, there was no difference in band intensity between non-induced and 
induced cultures of bacteria transformed with the synthetic PfMCA1 gene. If PfMCA1 was 
indeed expressed, a band approximately 98 kDa in size, which is the total weight of the 
PfMCA1 protein and GST moiety, would be observed in bacteria grown with induction. It is 
possible that even if an increase in band intensity was not observed, it could still be detected 
with an immunoblot. However, the immunoblot results suggest otherwise, that no PfMCA1 
protein had been expressed. 
In E. coli, factors that prevent the soluble expression of plasmodial proteins include 
molecular weights of 56 kDa and beyond, greater protein disorder, isoelectric points of 6 and 
above, lack of homology to E. coli proteins, regions of low complexity (>29%) and 
plasmodium-specific protein motifs (Birkholtz et al., 2008). Examination of chromosomes 2 
and 3 of P. falciparum revealed that a high percentage of the proteins coded for within those 
chromosomes contain regions of low complexity (Pizzi and Frontali, 2001), and it stands to 
reason that this is characteristic of the entire P. falciparum proteome (Gardner et al., 2002). 
The abundance of low complexity regions have been implicated as a mechanism for the 
malarial parasite to avoid host immune responses via antigenic variability (Dodin and Levoir, 
2005). 
Regions of low complexity can be determined bioinfomatically using SEG (Wootton 
and Federhen, 1996). SEG analysis showed that almost 43% of the protein consists of low 
complexity regions. Furthermore, PfMCA1 has a predicted size of 71.7 kDa and a predicted 
pI of 8.7 (PlasmoDB), and together, these factors would pose a formidable obstacle, and 








4.4 PfMCA1 expression in T. brucei 
Other bloodborne unicellular protozoan parasites possessing metacaspases include 
Trypanosoma and Leishmania. Five metacaspases have been identified in metacaspases, of 
which metacaspases 2, 3 and 5 have associated with the endosome pathway (Helms et al., 
2006). Metacaspase 4 have been implicated in cell death, as heterologous expression induced 
respiratory deficiency in S. cerevisiae (Szallies et al., 2002). The role of metacaspase 1 
remains unknown at this point in time. 
T. brucei has previously been used as an expression host (Gannavaram et al., 2008), 
and are easy to cultivate and genetically manipulate. Transient expression of PfMCA1 tagged 
to YFP at the C-terminus in trypansomes did reveal successful expression, but the level of 
expression is extremely low compared to a control performed with an empty vector. In a 10 µl 
volume of control culture, glowing trypanosomes were plentiful and could be detected easily. 
In contrast, an average of ten positive trypansomes could be detected in the same 10 µl 
volume of culture that was transformed with PfMCA1. It is noteworthy that PfMCA1 
expression could be detected in both healthy and dying trypanosomes, suggesting that 
PfMCA1 is somehow involved in the cell death pathway. Coupled with the low expression 
level, it hints that the inability to express PfMCA1 may be a result of the protein itself. 
The yellow fluorescence was observed throughout the entire cell, and was not 
compartmentalized to any particular organelle, suggesting that PfMCA1-YFP is distributed in 
the cytoplasm. In contrast, heterologous expression of TbMCA4-GFP fusion proteins in S. 
cerevisiae demonstrated a nuclear localization. Similarly, YCA1-GFP fusion proteins also 
localized in the nucleus. However, the same YCA1-GFP protein could also be observed 
throughout the entire cell (Szallies et al., 2002, suggesting that YCA1 is involved in a variety 
of biological processes before and during cell death, but the nucleus is where most of its 
effects are felt. On the other hand, the effect of TbMCA4 seems to be localized to the nucleus. 
It seems that not unlike YCA1, PfMCA1 exerts its effects globally, but this result is 
presumptive at best without more concrete evidence. 




Concurrent with the effort to express PfMCA1 in T. brucei, a system was being set up 
in T. brucei to investigate the effect of PfMCA1 on trypanosome cell death. It was decided 
that metacaspase 4 of T. brucei (TbMCA4) would be silenced, and a phenotypic rescue would 
be attempted with PfMCA1. Concanavalin A (ConA) have been shown to kill procyclic T. 
brucei (Acosta-Serrano et al., 2000), and it appears to do so with apoptotic characteristics 
(Welburn et al., 1996). Treatment of T. brucei cells with ConA causes the cells to lose their 
characteristic morphology, and become round. Treated cells will also tend to agglutinate. 
These observations are in agreement with what was previously described by Welburn et al 
(1996). 
A clone was previously isolated that demonstrated RNAi silencing of TbMCA4. 
Preliminary data indicates that the TbMCA4-silenced culture was more resistant to cell death 
induced by ConA, as compared to a culture that did not have the TbMCA4 gene silenced. 
Silenced cultures also tend to have more motile trypanosomes that retained their characteristic 
morphology and less agglutination, as compared to the non-silenced cultures. However, the 
cultures recovered if left overnight, suggesting that the concentration of ConA used (2.5 
µg/ml) might have been too little to last a prolonged period of time. Welburn et al. used 50 
µg/ml ConA, which in our hands, caused a massive dying of cells, making it impossible to 
obtain any meaningful results. 
These results indicate that TbMCA4 could have a possible role in the ConA-induced 
cell death pathway of T. brucei. However, as PfMCA1 did not express very well in 
trypanosomes, no further optimization of the ConA assay was carried out. The data does 
suggest that with further optimization of the conditions, this assay could prove to be useful for 
investigation of PCD in trypanosomes. Nevertheless, it should be noted that the presence of 
other metacaspases in T. brucei pose a risk of redundancy. Even though metacaspases 2, 3 
and 5 have not been implicated in trypanosomal cell death, the role of metacaspase 1 has not 
been fully elucidated, and it is possible that any combination of these metacaspases might be 
able to assume the functions of TbMCA4. 
 




4.5 Over-expression of YCA1 
S. cerevisiae actin could be successfully over-expressed under the appropriate 
conditions, indicating that the expression system employed could not have prevented 
PfMCA1 expression. This suggested that a factor intrinsic to PfMCA1 is responsible for the 
inabilty to detect PfMCA1 expression. Curiously, neither could YCA1 be expressed as well, 
even though previous studies have successfully done so (Bettiga et al., 2004; Madeo et al., 
2002; Watanabe and Lam 2005). Instead of using genomic DNA as the source, the YCA1 
coding sequence was amplified from previously-isolated RNA. Using this fragment, 
recombinant YCA1 could be successfully detected. This is enigmatic, as the DNA sequences 
are virtually identical, as evidenced by DNA sequencing. 
The exact mechanism of YCA1 processing is unknown, but it has been postulated to 
be similar to that of initiator caspases (Madeo et al., 2002; Watanabe and Lam 2005). Initiator 
caspases are present in the cell as inactive zymogens, which are able to undergo self-
activation via autocatalysis. Overexpressed YCA1 was cleaved in transformed WT cells, 
while there was no such processing observed in transformed ∆YCA1 cells. This pattern of 
YCA1 processing certainly suggests an autocatalytic mechanism.  
Without any form of cell signalling to initiate the processing, autocatalysis could only 
occur if the concentration of YCA1 in the cell reached a certain critical threshold level. In WT 
yeast cells, there already exists an endogenous pool of YCA1 molecules. It is therefore not 
inconceivable that upon induction of YCA1 expression, the concentration of YCA1 in the cell 
would reach a level sufficiently high enough to initiate autocatalysis, leading to the cleavage 
pattern observed in the immunoblot. In contrast, ∆YCA1 yeast cells lack any form of 
endogenous YCA1, and even with the overexpression, the level of YCA1 was not sufficiently 
high to cause autocatalysis. Thus, any YCA1 proteins heterologously expressed in ∆YCA1 
yeast cells remained unprocessed, and were observed as full length proteins. 
 
 




4.6 Amplification of PfMCA1 from RNA 
As it seems that the coding sequence obtained from mRNA seemed to be much better 
suited for expression, mRNA was isolated from P. falciparum, in the hopes that a PfMCA1 
mRNA transcript might be amplified for gene expression. Despite repeated attempts, no full-
length mRNA transcript could be obtained. 
Using PfMCA1 sequencing primers, it was possible to amplify segments of PfMCA1 
from cDNA (results not shown). The largest fragment that was obtained spanned a region 
starting from nucleotide positions 519 to 1227 of the PfMCA1 coding sequence, a region that 
lies within the postulated non-catalytic domain (the catalytic domain starts from nucleotide 
position1651). This fragment was obtained using the primers PfMCA-pESC-fw-4893 and 
PfMCA-pESC-rv-5601. No PCR product was obtained when using sequencing primers which 
amplified outside of this region. 
In contrast, other studies utilising microarray analyses and RT-PCR showed that the 
PfMCA1 gene was actively transcribed (Wu et al., 2003), and that it could be amplified from 
a cDNA library (Deponte and Becker, 2004). Certainly, evidence suggests that amplification 
of the full-length transcript should be possible, yet it is curious that that is not the case in our 
hands. 
Laboratory culture represent a stringent set of conditions to which the organism being 
cultured has to adapt to. In vitro conditions are optimized for the organism’s growth and 
reproduction, and differ greatly from conditions in its natural environment. For example, P. 
falciparum demonstrated down-regulation of PfEMP1 when field isolates were cultivated in 
vitro (Peters et al., 2007). Presumably, the lack of an immune response under in vitro 
conditions would signal the parasites that a strong var response is no longer required for 
immune evasion, and resources could be better utilized elsewhere. It is possible that extended 
culture of a laboratory-attenuated strain such as 3D7 might have led to post-transcriptional 
modifications of PfMCA1 mRNA to better suit its purposes, preventing successful 
amplification from RNA. Internal mutations leading to primer annealing failure are unlikely, 
as the PfMCA1 genomic sequence is identical to the one stored on the PlasmoDB database. 




Another possibility is that the predicted gene sequence is incorrect, leading to inaccurate 
intron/exon predictions (PfMCA1 is predicted to have no introns), and other misinformation 
(Lu et al., 2007) 
 
4.7 Expression of PfMCA1 variants 
All classical caspases possess the same three-dimensional characteristics, quaternary 
arrangement and catalytic mechanism (Grütter, 2000). The imidazole group of the histidine 
residue reacts with the sidechain of the cysteine residue, activating it via polarization. Both 
the activated cysteine residue and the histidine residue cooperate to proteolytically cleave the 
substrate molecule. Metacaspases have been predicted to possess the same two residues, and 
it is possible that their mechanism is largely similar to caspases. 
It is possible that the activity of PfMCA1 may be preventing any expression. To test 
that hypothesis, the cysteine residue of the catalytic dyad in PfMCA1 was mutated to an 
alanine residue via site-directed mutagenesis. The cysteine residue was chosen as the first 
amino acid to be mutated as previous studies have shown that the cysteine residue plays a 
more important role in the enzymatic activity of metacaspases, and hence their functional role 
in programmed cell death, as compared to the histidine residue (Gonzáles et al., 2007; 
Szallies et al., 2002; Watanabe and Lam, 2005). 
Disappointingly, no PfMCA1 expression could be detected. Originally, it was hoped 
that other site-directed mutants, namely one where only the critical histidine residue had been 
similarly mutated to alanine, and a dual-mutation where both residues were mutated, could be 
generated, and these mutants could subsequently be tested for the individual and additive 
effects of such mutations on protein expression. However, previous efforts at troubleshooting 
and repeating protocols meant there was little time left to examine whether these mutants 
would have been successfully expressed. 
 
In addition to the site-directed mutants, the catalytic and non-catalytic domains were 
also expressed in S. cerevisiae. No expression of the PfMCA1 catalytic domain could be 




detected, but expression of the non-catalytic domain was successful. These results implied 
that the catalytic domain, and by extension its catalytic activity, is toxic to the yeast cells, or 
any other host organism. In response, the host organism either degrades the protein, or only 
allows an undetectable low-level expression. This is not unique to PfMCA1, other enzymes 
such as kinases are unable to be expressed heterologously unless their enzymatic activity had 
been attenuated (Kemble et al., 2006; Piserchio et al., 2009) 
Despite the successful expression, expression levels of the non-catalytic domain were 
extremely low in ∆YCA1 yeast cells. In contrast, intense bands were observed in WT yeast 
cells. This discrepancy is unexpected, as there would be no plausible reason why the non-




Figure 14. Schematic summary of PfMCA1 expression in S. cerevisiae. 
The full-length PfMCA1 protein could not be expressed in yeast, and neither could a mutant with the critical 
cysteine residue replaced with an alanine. PfMCA1 can be broadly divided into non-catalytic and catalytic 
domains. While expression of the catalytic domain could not be detected, the non-catalytic domain could be 
expressed and detected in yeast cells under inducing conditions. Curiously, expression of the non catalytic 
domain was significantly lesser in ∆YCA1 yeast cells than WT cells. 
 




4.8 Future strategies for successful PfMCA1 expression 
While a variety of expression hosts have been examined in their ability to express 
PfMCA1, there still remain other alternatives. A promising alternative is the baculovirus 
system (Birkholtz et al., 2008). A significant advantage of the baculovirus expression system 
is that it recognizes various eukaryotic targeting and post-translational modification signals. 
Plasmodial proteins expressed in a baculovirus system are therefore likely to remain soluble 
and possess a native folding pattern. This approach has been successfully used to study the 
biochemical characteristics of plasmodial proteins (Chia et al., 2005; Rayavara et al., 2009) 
and for vaccine production (Lyon et al., 2008; Strauss et al., 2007; Yoshida et al., 2009). 
Besides the baculovirus expression system, the slime mold Dictyostelium discoideum 
could also prove to be an attractive expression host for plasmodial proteins. It is relatively 
easy to culture and genetically manipulate (Birkholtz et al., 2008), and it also possesses 
caspase-like proteins called paracaspases (Uren et al., 2000). D. discoideum has already been 
used to study cell death pathways (Tresse et al., 2008), and the (A+T)-bias of its genome is 
similar to that of P. falciparum (Szafranski et al., 2005), making it more likely that any 
plasmodial proteins would be expressed without any significant problems. D. discoideum is 
therefore an attractive host system in which to functionally characterize plasmodial proteins. 
To date, several plasmodial proteins have been successfully expressed in D. disoideum (Fasel 
et al., 1992; Naudé et al., 2005; Sá et al., 2006; van Bemmelen et al., 2000). 
Increased yield of PfMCA1 can also be achieved by fusing to it highly-stable proteins 
such as human γ-interferon and ubiquitin. This has been used successfully to obtain high 
yields of P. falciparum SERA proteins (Barr et al., 1991). While this could boost the amount 
of protein available for study, the fusion protein could lead to complications in biochemical 
analyses. It could also lead to immunogenicity problems, and plasmodial proteins produced in 
this manner are not used for therapeutic intervention (Bathurst, 1994). 
A relatively new approach to the heterologous expression of plasmodial proteins, 
termed ‘codon harmonization’, takes into account the rate of protein translation in the 
parasite, and attempts to replicate the same rate in the expression host (Angov et al., 2008). 




The rate of peptide elongation varies throughout the entire translation process, and at regions 
where translation slows down, partial folding of the protein can occur, increasing the stability 
of the nascent protein. Replacing these regions with high-abundance codons would prevent 
such stabilization, with the result that protein expression is significantly decreased. This 
approach has been used successfully to express plasmodial proteins which are potential 
vaccine candidates (Angov et al., 2008; Chowdhury et al., 2009). 
Biochemical analysis of PfMCA1 had been hampered by the lack of protein 
expression, due to the perceived toxicity. It is possible to bypass any intracellular 
accumulation by attaching a secretory signal to PfMCA1. Any PfMCA1 produced would 
therefore be transported out of the cell into the extracellular medium via the secretory 
pathway, and can be purified. The secretory pathway minimizes any contact PfMCA1 might 
have with intracellular components, and thus increases the tolerance the cell might have for 
PfMCA1. This approach has been used to express a variety of proteins such as human serum 
albumin (Sleep et al., 1990), HIV proteins (Lasky et al., 1986) and cellulase complexes (Van 
Rensburg et al., 1998). The yeast α-factor mating pheromone is most commonly used for this 
purpose (Bathurst, 1994), and it involves the addition of the α-factor signal leader sequence to 
the N-terminus of the protein. The signal sequence is cleaved off before secretion, forming 
the mature protein with a correct N-terminus. Plasmodial proteins produced in this manner 
have been successfully used to illicit antibody responses (Barr et al., 1991; Gozar et al., 
1998), for vaccine cocktails (Bathurst et al., 1993). 
An alternative to the heterologous expression of PfMCA1 would be to knock out, or 
down-regulate, the expression of PfMCA1 in P. falciparum parasites themselves. Traditional 
approaches to create gene knockouts in Plasmodium parasites via homologous recombination 
events require a long period of time (typically 3 months), and this is further hampered by the 
low levels of efficiences in introducing the DNA into the parasites (Gardiner et al., 2003; 
Skinner-Adams et al., 2003). While this approach had been considered during the couse of 
this study (for understanding PfMCA1 functions), the impracticalites (a long period of time 




required to generate successful mutants and unfamilarity with the techniques involved) 
precluded it from being put into use. 
In recent years, transposon mutagenesis has been used to study functional analysis of 
the Plasmodium genome (Balu et al., 2005, 2009; Balu and Adams, 2006). Compared to 
traditional methods, piggyBac transposon-mediated mutagenesis is more efficient. Although 
this method randomly integrates into the genome, it is possible to obtain mutants with only 
one, single piggyBac insertion (Balu et al., 2009). It is then possible to screen for mutants of 
the gene of interest. 






A literature survey only revealed one study that has managed to successfully express 
PfMCA1 (Meslin et al., 2007). Expressed PfMCA1 proteins appear to be processed in a 
similar fashion as caspases. However, the study did not characterize the functional aspects of 
PfMCA1, and its role in programmed cell death remains unknown. 
Although PfMCA1 had been successfully cloned, it could not be expressed in S. 
cerevisiae, E. coli, and only at extremely low levels in T. brucei, despite our best efforts. 
Further investigation revealed that the most probable reason for this is the catalytic activity of 
PfMCA1. The non-catalytic domain of the protein could be successfully expressed, but the 
catalytic domain remained unexpressed. Suppression of the catalytic activity via site-directed 
mutagenesis did not prevent non-expression. However, only a clone where the cysteine 
residue of the catalytic dyad was mutated to alanine was generated. No clones in which the 
histidine residue or both the residues were mutated, were generated. The possibility remains 
that expression of the full-length PfMCA1 protein could be achieved if the catalytic activity 
was suppressed further, or even abolished altogether. 
We have shown that the most reasonable explanation for the inability to express 
PfMCA1 in a variety of host organisms lies with the toxicity of its catalytic domain. Future 
directions for PfMCA1 would ideally expand on characterizing its catalytic function, and how 
it affects its own expression. The difficulties experienced in expressing this particular protein 
could explain why there is a dearth of information about it in current literature. PfMCA1-
knockouts in P. falciparum would also complement any data obtained from function-
complementation studies 
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7.1 PCR primers 




































Underlined bases represent restriction sites. 




7.2 Sequencing primers 


































Sequences with the same symbol after their name have the same nucleotide 
sequences.




















7.5 pESC-HIS  
 
  Electropherogram of PfMCA1 with a C460A mutation. The sequencing was done in the 3’→5’ direction, hence the results are a reverse-complement of the 
coding sequence. The mutation is boxed in grey 
7.6 Electropherogram of PfMCA C460A mutant 
























































































































































































































7.7 Data from ConA assay 
[ConA] = 1.0 µg/ml 
 
Raw Data Cell Count 






(hr) ConA- ConA+ ConA- ConA+ ConA- ConA+ ConA- ConA+ 
24 24 4 4 9 6 2000000 2000000 4500000 3000000 
48 48 24 6 24 12 12000000 3000000 12000000 6000000 
72 72 42 17 41 29 21000000 8500000 20500000 14500000 
96 
1 
96 26 16 25 26 13000000 8000000 12500000 13000000 
24 24 15 12 7 7 7500000 6000000 3500000 3500000 
48 48 28 15 29 13 14000000 7500000 14500000 6500000 




96 24 32 33 33 12000000 16000000 16500000 16500000 
Average Cell Count Standard Error 
Tet- Tet+ Tet- Tet+ 
Time 
[ConA] 
(µg/ml) ConA- ConA+ ConA- ConA+ ConA- ConA+ ConA- ConA+ 
24 4750000 4000000 4000000 3250000 2750000 2000000 500000 250000 
48 13000000 5250000 13250000 6250000 1000000 2250000 1250000 250000 
72 18000000 11500000 26250000 14000000 3000000 3000000 5750000 500000 
96 
1.0 
12500000 12000000 14500000 14750000 500000 4000000 2000000 1750000 
























































































































































































































[ConA] = 2.5 µg/ml 
Raw Data Cell Count 





ConA- ConA+ ConA- ConA+ ConA- ConA+ ConA- ConA+ 
24 15 2 12 0 7500000 1000000 6000000 0 
48 46 5 29 1 23000000 2500000 14500000 500000 
72 28 9 47 12 14000000 4500000 23500000 6000000 
96 
1 
14 6 21 8 7000000 3000000 10500000 4000000 
24 11 1 15 11 5500000 500000 7500000 5500000 
48 30 0 40 12 15000000 0 20000000 6000000 
72 48 12 30 10 24000000 6000000 15000000 5000000 
96 
2 
20 6 26 13 10000000 3000000 13000000 6500000 
24 17 3 17 1 8500000 1500000 8500000 500000 
48 66 4 43 8 33000000 2000000 21500000 4000000 




23 7 27 11 11500000 3500000 13500000 5500000 




























































































































































































































Average Cell Count Standard Error 
Tet- Tet+ Tet- Tet+ 
Time 
[ConA] 
(µg/ml) ConA- ConA+ ConA- ConA+ ConA- ConA+ ConA- ConA+ 
24 7166666.7 1000000 7333333 2000000 881917.1 288675.1 726483.2 1755942 
48 23666667 1500000 18666667 3500000 5206833 763762.6 2127858 1607275 
72 19666667 4666667 19666667 5833333 2962731 726483.2 2488864 440958.6 
96 
2.5 
9500000 3166667 12333333 5333333 1322876 166666.7 927960.7 726483.2 
























































































































































































































Student’s t-test (unpaired, two-tailed, unequal variance) 
Tet- Tet+ [ConA] 
(µg/ml) 
Time Sample 
ConA- ConA+ Con- ConA+ 
1 2000000 2000000 4500000 3000000 
24 
2 7500000 6000000 3500000 3500000 
p-value 0.4237996 0.1749428 
1 12000000 3000000 12000000 6000000 
48 
2 14000000 7500000 14500000 6500000 
p-value 0.0689624 0.050831 
1 21000000 8500000 20500000 14500000 
72 
2 15000000 14500000 32000000 13500000 
p-value 0.1325983 0.1386873 
1 13000000 8000000 12500000 13000000 
96 
2 12000000 16000000 16500000 16500000 
1.0 
p-value 0.4604844 0.4668806 
























































































































































































































Tet- Tet+ Tet- Tet+ [ConA] 
(µg/ml) 
Time Sample 
ConA- ConA+ ConA- ConA+ 
1 7500000 1000000 6000000 0 
2 5500000 500000 7500000 5500000 24 
3 8500000 1500000 8500000 500000 
p-value 0.0065394 0.0386569 
1 23000000 2500000 14500000 500000 
2 15000000 0 20000000 6000000 48 
3 33000000 2000000 21500000 4000000 
p-value 0.0241525 0.0029265 
1 14000000 4500000 23500000 6000000 
2 24000000 6000000 15000000 5000000 72 
3 21000000 3500000 20500000 6500000 
p-value 0.0154381 0.0138861 
1 7000000 3000000 10500000 4000000 
2 10000000 3000000 13000000 6500000 96 
3 11500000 3500000 13500000 5500000 
2.5 
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